TSSK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Log-Odds: S Sites / S Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0JLT2 | S239 | Sugiyama | MED19 LCMR1 | KKKKNRHsPDHPGMGssQAssSSSLR_______________ |
| A0MZ66 | S473 | Sugiyama | SHTN1 KIAA1598 | LGtLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADss |
| A4FU28 | S138 | Sugiyama | CTAGE9 | EKAAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKS |
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| A6NDS4 | T152 | Sugiyama | TBC1D3B TBC1D3I | KEKGKRSSEHIQRIDRDISGtLRKHMFFRDRYGTKQRELLH |
| A6NKT7 | S978 | Sugiyama | RGPD3 RGP3 | GRGVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSG |
| A6NKT7 | S980 | Sugiyama | RGPD3 RGP3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| A6NMY6 | S127 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| B9A6J9 | T152 | Sugiyama | TBC1D3L PRC17 | KEKGKRSSEHIQRIDRDVSGtLRKHIFFRDRYGTKQRELLH |
| O00151 | S84 | Sugiyama | PDLIM1 CLIM1 CLP36 | LEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGKRHPYKM |
| O00151 | T80 | Sugiyama | PDLIM1 CLIM1 CLP36 | NMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGKRH |
| O00231 | S298 | Sugiyama | PSMD11 | RYAGRQTEALKCVAQASKNRsLADFEKALTDYRAELRDDPI |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00273 | S302 | Sugiyama | DFFA DFF1 DFF45 H13 | TETVQEACERELALRLQQtQsLHsLRsIsAsKAsPPGDLQN |
| O00410 | S726 | Sugiyama | IPO5 KPNB3 RANBP5 | LMVPLLKFYFHDGVRVAAAEsMPLLLECARVRGPEYLTQMW |
| O14715 | S977 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | GRGVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSG |
| O14715 | S979 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15226 | T620 | Sugiyama | NKRF ITBA4 NRF | KIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQIA |
| O15355 | S349 | Sugiyama | PPM1G PPM1C | tTAVVALIRGKQLIVANAGDsRCVVsEAGKALDMsyDHKPE |
| O43399 | S21 | Sugiyama | TPD52L2 | MDsAGQDINLNsPNKGLLsDsMtDVPVDTGVAARtPAVEGL |
| O43464 | S435 | Sugiyama | HTRA2 OMI PRSS25 | AIGEQMVQNAEDVYEAVRTQsQLAVQIRRGRETLTLYVTPE |
| O43815 | S229 | Sugiyama | STRN | TEAEVKETAMIAKSELtDsAsVLDNFKFLEsAAADFsDEDE |
| O43823 | S124 | Sugiyama | AKAP8 AKAP95 | SKEGGRGGsGGGGEGIQDREssFRFQPFESYDSRPCLPEHN |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60291 | S515 | Sugiyama | MGRN1 KIAA0544 RNF156 | sFItEEVDESssPQQGTRAAsIENVLQDssPEHCGRGPPAD |
| O60333 | S1603 | Sugiyama | KIF1B KIAA0591 KIAA1448 | TKCLQLLTHTFNREFSQVHGsVsDCKLsDIsPIGRDPSESS |
| O60333 | S1605 | Sugiyama | KIF1B KIAA0591 KIAA1448 | CLQLLTHTFNREFSQVHGsVsDCKLsDIsPIGRDPSESSFS |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60763 | S245 | Sugiyama | USO1 VDP | GGIVVEDCLILLQNLLKNNNsNQNFFKEGSYIQRMKPWFEV |
| O60763 | S32 | Sugiyama | USO1 VDP | SAGPQHTEAEtIQKLCDRVAssTLLDDRRNAVRALKSLSKK |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O75116 | T573 | Sugiyama | ROCK2 KIAA0619 | STEKVNQLQRQLDEtNALLRtESDTAARLRKTQAESSKQIQ |
| O75179 | S243 | Sugiyama | ANKRD17 GTAR KIAA0697 | RAEStANAGQSDNRSLAEACsEGDVNAVRKLLIEGRSVNEH |
| O75390 | S453 | Sugiyama | CS | LAQLIWSRALGFPLERPKSMsTEGLMKFVDSKSG_______ |
| O75822 | S127 | Sugiyama | EIF3J EIF3S1 PRO0391 | VLtPEEQLADKLRLKKLQEEsDLELAKEtFGVNNAVyGIDA |
| O75822 | S202 | Sugiyama | EIF3J EIF3S1 PRO0391 | VLVRDVCISLEIDDLKKITNsLTVLCsEKQKQEKQSKAKKK |
| O76003 | S118 | Sugiyama | GLRX3 PICOT TXNL2 HUSSY-22 | DRLDGAHAPELTKKVQRHAssGsFLPSANEHLKEDLNLRLK |
| O76003 | S120 | Sugiyama | GLRX3 PICOT TXNL2 HUSSY-22 | LDGAHAPELTKKVQRHAssGsFLPSANEHLKEDLNLRLKKL |
| O76021 | S314 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | RNFEKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKKPE |
| O76070 | S51 | Sugiyama | SNCG BCSG1 PERSYN PRSN | EKTKEGVMyVGAKtKENVVQsVTsVAEKTKEQANAVSEAVV |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95155 | S118 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | QsLsRsQsMDIDGVSCEKsMsQVDVDsGIENMEVDENDRRE |
| O95197 | T318 | Sugiyama | RTN3 ASYIP NSPL2 | RNKEAGRYPMSALLSRQFsHtNAALEEVSRCVNDMHNFTNE |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95817 | S184 | Sugiyama | BAG3 BIS | AsHGPERsQsPAAsDCsssSsSAsLPssGRssLGsHQLPRG |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P01023 | S593 | Sugiyama | A2M CPAMD5 FWP007 | SPSQSLPASHAHLRVTAAPQsVCALRAVDQSVLLMKPDAEL |
| P01130 | S286 | Sugiyama | LDLR | DEVGCVNVTLCEGPNKFKCHsGECITLDKVCNMARDCRDWS |
| P02545 | S295 | Sugiyama | LMNA LMN1 | RQsAERNsNLVGAAHEELQQsRIRIDsLsAQLsQLQKQLAA |
| P02786 | S10 | Sugiyama | TFRC | ___________MMDQARsAFsNLFGGEPLsytRFsLARQVD |
| P02786 | S19 | Sugiyama | TFRC | __MMDQARsAFsNLFGGEPLsytRFsLARQVDGDNsHVEMK |
| P02786 | S361 | Sugiyama | TFRC | AAEKLFGNMEGDCPSDWKTDstCRMVTSESKNVKLTVSNVL |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S187 | Sugiyama | HSPB1 HSP27 HSP28 | APMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAAK__ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05023 | S519 | Sugiyama | ATP1A1 | sEPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQ |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S19 | Sugiyama | RPLP2 D11S2243E RPP2 | __MRyVAsyLLAALGGNssPsAKDIKKILDsVGIEADDDRL |
| P05387 | S6 | Sugiyama | RPLP2 D11S2243E RPP2 | _______________MRyVAsyLLAALGGNssPsAKDIKKI |
| P05387 | Y3 | Sugiyama | RPLP2 D11S2243E RPP2 | __________________MRyVAsyLLAALGGNssPsAKDI |
| P05387 | Y7 | Sugiyama | RPLP2 D11S2243E RPP2 | ______________MRyVAsyLLAALGGNssPsAKDIKKIL |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P05556 | S675 | Sugiyama | ITGB1 FNRB MDF2 MSK12 | GEKKDTCTQECSYFNITKVEsRDKLPQPVQPDPVsHCKEKD |
| P05783 | S401 | Sugiyama | KRT18 CYK18 PIG46 | RRLLEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVVsE |
| P05787 | S280 | Sugiyama | KRT8 CYK8 | IAEVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDL |
| P06737 | S831 | Sugiyama | PYGL | KFSSDRTIKEyAQNIWNVEPsDLKIsLSNESNKVNGN____ |
| P06744 | S107 | Sugiyama | GPI | GEKINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLD |
| P06756 | S955 | Sugiyama | ITGAV MSK8 VNRA VTNR | TETFMNKENQNHSYSLKSSAsFNVIEFPYKNLPIEDITNST |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07339 | S42 | Sugiyama | CTSD CPSD | VRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQAVPAV |
| P07339 | T35 | Sugiyama | CTSD CPSD | AAPASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKY |
| P07355 | S127 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| P07384 | S474 | Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | S814 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KTGQEYKPGNPPAEIGQNIssNssAsILESKsLyDEVAAQG |
| P07814 | S816 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | GQEYKPGNPPAEIGQNIssNssAsILESKsLyDEVAAQGEV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P08195 | S286 | Sugiyama | SLC3A2 MDU1 | KNQKDDVAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVIL |
| P08195 | S518 | Sugiyama | SLC3A2 MDU1 | DIPGAVSANMTVKGQsEDPGsLLsLFRRLsDQRsKERSLLH |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S490 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRKRGFEV |
| P08238 | S532 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yMtEPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| P08865 | S138 | Sugiyama | RPSA LAMBR LAMR1 | EPRLLVVTDPRADHQPLtEAsyVNLPtIALCNTDSPLRyVD |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0CAP2 | S187 | Sugiyama | POLR2M GRINL1A | EASEHHPRHRVssQAEDtSssFDNLFIDRLQRITIADQGEQ |
| P0CG41 | S138 | Sugiyama | CTAGE8 | EKAAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKS |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DJD0 | S962 | Sugiyama | RGPD1 RANBP2L6 RGP1 | GRGVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSG |
| P0DJD0 | S964 | Sugiyama | RGPD1 RANBP2L6 RGP1 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P10809 | S410 | Sugiyama | HSPD1 HSP60 | LNERLAKLsDGVAVLKVGGtsDVEVNEKKDRVtDALNAtRA |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11279 | S141 | Sugiyama | LAMP1 | NLSDTHLFPNASSKEIKtVEsITDIRADIDKKYRCVSGTQV |
| P11279 | T138 | Sugiyama | LAMP1 | FVYNLSDTHLFPNASSKEIKtVEsITDIRADIDKKYRCVSG |
| P11586 | S318 | Sugiyama | MTHFD1 MTHFC MTHFD | FKPGKWMIQYNNLNLKTPVPsDIDIsRSCKPKPIGKLAREI |
| P11586 | S765 | Sugiyama | MTHFD1 MTHFC MTHFD | ARMFGIPVVVAVNAFKTDTEsELDLIsRLSREHGAFDAVKC |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12270 | S909 | Sugiyama | TPR | NTKELLKNAQKEIATLKQHLsNMEVQVASQSSQRTGKGQPs |
| P13073 | S89 | Sugiyama | COX4I1 COX4 | SWssLsMDEKVELYRIKFKEsFAEMNRGSNEWKTVVGGAMF |
| P13473 | S155 | Sugiyama | LAMP2 | LTVDELLAIRIPLNDLFRCNsLSTLEKNDVVQHYWDVLVQA |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13674 | S395 | Sugiyama | P4HA1 P4HA | TVHYRISKsAWLsGyENPVVsRINMRIQDLTGLDVSTAEEL |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13797 | S540 | Sugiyama | PLS3 | NDDIIVNWVNRTLSEAGKSTsIQSFKDKTISSSLAVVDLID |
| P13798 | S187 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | EKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQFV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P14868 | S192 | Sugiyama | DARS1 DARS PIG40 | ATVNQDTRLDNRVIDLRTsTsQAVFRLQSGICHLFRETLIN |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P16083 | S80 | Sugiyama | NQO2 NMOR2 | LSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKVREADLVIF |
| P16333 | S85 | Sugiyama | NCK1 NCK | ASIVKNLKDTLGIGKVKRKPsVPDsAsPADDsFVDPGERLy |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16949 | S16 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | _____MAssDIQVKELEKRAsGQAFELILsPRsKEsVPEFP |
| P16949 | S46 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | PRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAEERRKsHEA |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18031 | S15 | Sugiyama | PTPN1 PTP1B | ______MEMEKEFEQIDKsGsWAAIyQDIRHEASDFPCRVA |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18754 | S85 | Sugiyama | RCC1 CHC1 | IPEDVVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsV |
| P18858 | S388 | Sugiyama | LIG1 | SVRAEAAEKGDVGLVAENSRsTQRLMLPPPPLTASGVFSKF |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19338 | S356 | Sugiyama | NCL | LAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKVFGNEI |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20674 | S104 | Sugiyama | COX5A | PEPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYP |
| P20700 | T544 | Sugiyama | LMNB1 LMN2 LMNB | GEDVKVILKNsQGEEVAQRstVFKttIPEEEEEEEEAAGVV |
| P21108 | S10 | Sugiyama | PRPS1L1 PRPS3 PRPSL | ___________MPNIKIFsGssHQDLSQKIADRLGLELGKV |
| P21108 | S11 | Sugiyama | PRPS1L1 PRPS3 PRPSL | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P21333 | S1029 | Sugiyama | FLNA FLN FLN1 | VGPSGAAVPCKVEPGLGADNsVVRFLPREEGPYEVEVTYDG |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21333 | S2158 | Sugiyama | FLNA FLN FLN1 | GRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQDMtAQV |
| P22059 | S386 | Sugiyama | OSBP OSBP1 | ITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLEETKKEKR |
| P22061 | S9 | Sugiyama | PCMT1 | ____________MAWKSGGAsHSELIHNLRKNGIIKTDKVF |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23921 | S119 | Sugiyama | RRM1 RR1 | EDLyNyINPHNGKHSPMVAKstLDIVLANKDRLNsAIIYDR |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25398 | S107 | Sugiyama | RPS12 | EWVGLCKIDREGKPRKVVGCsCVVVKDYGKESQAKDVIEEy |
| P25788 | S34 | Sugiyama | PSMA3 HC8 PSC8 | tFsPDGRVFQVEYAMKAVENssTAIGIRCKDGVVFGVEKLV |
| P26006 | S898 | Sugiyama | ITGA3 MSK18 | DPGGGQGPPPVTLAAAKKAKsETVLTCATGRAHCVWLECPI |
| P27348 | S63 | Sugiyama | YWHAQ | LLsVAyKNVVGGRRSAWRVIsSIEQKTDTSDKKLQLIKDYR |
| P27816 | S440 | Sugiyama | MAP4 | QANDIISSTEISSAEKVALssETEVALARDMtLPPETNVIL |
| P29353 | S426 | Sugiyama | SHC1 SHC SHCA | VRKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPP |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29401 | S332 | Sugiyama | TKT | GDKIATRKAYGQALAKLGHAsDRIIALDGDtKNstFsEIFK |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30044 | S101 | Sugiyama | PRDX5 ACR1 SBBI10 | LFKGKKGVLFGVPGAFtPGCsKtHLPGFVEQAEALKAKGVQ |
| P30048 | S199 | Sugiyama | PRDX3 AOP1 | SGLALRGLFIIDPNGVIKHLsVNDLPVGRSVEETLRLVKAF |
| P30086 | S99 | Sugiyama | PEBP1 PBP PEBP | PKYREWHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHR |
| P31153 | S38 | Sugiyama | MAT2A AMS2 MATA2 | FLFTSESVGEGHPDKICDQIsDAVLDAHLQQDPDAKVACET |
| P31327 | S835 | Sugiyama | CPS1 | MCHPsIEGFTPRLPMNKEWPsNLDLRKELSEPSsTRIyAIA |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31939 | S450 | Sugiyama | ATIC PURH OK/SW-cl.86 | SNSVCYAKNGQVIGIGAGQQsRIHCTRLAGDKANyWWLRHH |
| P31946 | S65 | Sugiyama | YWHAB | LLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQMGKEYR |
| P33981 | S455 | Sugiyama | TTK MPS1 MPS1L1 | QsPPISTSKWFDPKSICKtPssNtLDDYMsCFRtPVVKNDF |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35221 | S652 | Sugiyama | CTNNA1 | IRtPEELDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAI |
| P35579 | S1304 | Sugiyama | MYH9 | NVtGLLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQK |
| P35579 | S1808 | Sugiyama | MYH9 | KELKVKLQEMEGtVKsKYKAsITALEAKIAQLEEQLDNEtK |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39748 | S255 | Sugiyama | FEN1 RAD2 | CESIRGIGPKRAVDLIQKHKsIEEIVRRLDPNKYPVPENWL |
| P40227 | S200 | Sugiyama | CCT6A CCT6 CCTZ | KKQDEPIDLFMIEIMEMKHKsEtDtsLIRGLVLDHGARHPD |
| P41229 | S317 | Sugiyama | KDM5C DXS1272E JARID1C SMCX XE169 | ELsHsPEPCtKMTMRLRRNHsNAQFIESYVCRMCSRGDEDD |
| P41236 | S24 | Sugiyama | PPP1R2 IPP2 | STAsHRPIKGILKNKtsttssMVAsAEQPRGNVDEELSKKs |
| P41236 | T22 | Sugiyama | PPP1R2 IPP2 | AASTAsHRPIKGILKNKtsttssMVAsAEQPRGNVDEELSK |
| P42566 | S746 | Sugiyama | EPS15 AF1P | DFSTLSKVNNEDPFRSATSssVsNVVITKNVFEETSVKSED |
| P42766 | S29 | Sugiyama | RPL35 | LRGKKKEELLKQLDDLKVELsQLRVAKVTGGAASKLsKIRV |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46459 | S17 | Sugiyama | NSF | ____MAGRSMQAARCPTDELsLtNCAVVNEKDFQsGQHVIV |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46940 | S482 | Sugiyama | IQGAP1 KIAA0051 | LINRALESGDVNTVWKQLsssVtGLTNIEEENCQRYLDELM |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P48643 | S235 | Sugiyama | CCT5 CCTE KIAA0098 | VGGRLEDTKLIKGVIVDKDFsHPQMPKKVEDAKIAILTCPF |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | T396 | Sugiyama | NASP | KDGAVNGPsVVGDQtPIEPQtsIERLtEtKDGsGLEEKVRA |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49368 | S252 | Sugiyama | CCT3 CCTG TRIC5 | YIKNPRIVLLDssLEyKKGEsQtDIEITREEDFTRILQMEE |
| P49368 | S458 | Sugiyama | CCT3 CCTG TRIC5 | RAVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtW |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49792 | S1953 | Sugiyama | RANBP2 NUP358 | GRGVIFGQTSSTFTFADLAKstsGEGFQFGKKDPNFKGFSG |
| P49792 | S1955 | Sugiyama | RANBP2 NUP358 | GVIFGQTSSTFTFADLAKstsGEGFQFGKKDPNFKGFSGAG |
| P50395 | S270 | Sugiyama | GDI2 RABGDIB | MLNKPIEEIIVQNGKVIGVKsEGEIARCKQLICDPSyVKDR |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P50851 | S1237 | Sugiyama | LRBA BGL CDC4L LBA | NLTRETKLINDCHGsVSEAssEQKIAKLDVsNVAtDtERLE |
| P51532 | S1380 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEI |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P52272 | S528 | Sugiyama | HNRNPM HNRPM NAGR1 | IERMGsGVERMGPAIERMGLsMERMVPAGMGAGLERMGPVM |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52569 | S464 | Sugiyama | SLC7A2 ATRC2 CAT2 | KCsPEKDGLGssPRVTSKsEsQVTMLQRQGFSMRTLFCPSL |
| P53367 | S293 | Sugiyama | ARFIP1 | DLEELNLGPRDANTLPKIEQsQHLFQAHKEKYDKMRNDVSV |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S656 | Sugiyama | ACLY | IGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISR |
| P53999 | S17 | Sugiyama | SUB1 PC4 RPO2TC1 | ____MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPV |
| P54105 | S198 | Sugiyama | CLNS1A CLCI ICLN | TAEGQATLERLEGMLsQsVssQYNMAGVRtEDsIRDyEDGM |
| P54252 | S260 | Sugiyama | ATXN3 ATX3 MJD MJD1 SCA3 | IDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNLTSEE |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55769 | S122 | Sugiyama | SNU13 NHP2L1 | CSVTIKEGSQLKQQIQsIQQsIERLLV______________ |
| P57678 | S301 | Sugiyama | GEMIN4 | QNPYHQQALAEKVKEAERDVsLTSLAKLPSETIFVGCEFLH |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60891 | S10 | Sugiyama | PRPS1 | ___________MPNIKIFsGssHQDLSQKIADRLGLELGKV |
| P60891 | S11 | Sugiyama | PRPS1 | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P60900 | S175 | Sugiyama | PSMA6 PROS27 | DPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTV |
| P60900 | S177 | Sugiyama | PSMA6 PROS27 | AGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTVET |
| P61163 | T248 | Sugiyama | ACTR1A CTRN1 | PQKDETLETEKAQyyLPDGstIEIGPSRFRAPELLFRPDLI |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61978 | S417 | Sugiyama | HNRNPK HNRPK | DLAGsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITI |
| P61978 | S420 | Sugiyama | HNRNPK HNRPK | GsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITItGt |
| P61981 | S64 | Sugiyama | YWHAG | LLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKIEMVRA |
| P62191 | S244 | Sugiyama | PSMC1 | LyGPPGtGKTLLAKAVANQTsATFLRVVGSELIQKYLGDGP |
| P62258 | S156 | Sugiyama | YWHAE | AtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLGLALN |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62333 | S189 | Sugiyama | PSMC6 SUG2 | GCLLyGPPGTGKTLLARAVAsQLDCNFLKVVSSSIVDKyIG |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63241 | S75 | Sugiyama | EIF5A | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQ |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68431 | S58 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | KPHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQD |
| P78347 | S547 | Sugiyama | GTF2I BAP135 WBSCR6 | IIQVGNRIKFVIKRPELLTHsttEVTQPRtNtPVKEDWNVR |
| P78371 | S470 | Sugiyama | CCT2 99D8.1 CCTB | IADNAGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAI |
| P83436 | S559 | Sugiyama | COG7 UNQ3082/PRO10013 | NPAEYASLMEILYTLKEKGSsNHNLLAAPRAALTRLNQQAH |
| P84243 | S58 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | KPHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQD |
| Q00059 | S160 | Sugiyama | TFAM TCF6 TCF6L2 | RKAMTKKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQE |
| Q00587 | S350 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | HyPEMDARQERVEVLPQARAsWEsLDEEWRAPQAGsRtPVP |
| Q00613 | S344 | Sugiyama | HSF1 HSTF1 | LLsPtALIDsILREsEPAPAsVTALtDARGHTDtEGRPPsP |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01082 | S2184 | Sugiyama | SPTBN1 SPTB2 | ssPIPsPtsDRKAKTALPAQsAAtLPARtQEtPsAQMEGFL |
| Q01581 | S404 | Sugiyama | HMGCS1 HMGCS | YSLKVTQDATPGSALDKITAsLCDLKSRLDSRTGVAPDVFA |
| Q02818 | S224 | Sugiyama | NUCB1 NUC | RKLEEQQRRHREHPKVNVPGsQAQLKEVWEELDGLDPNRFN |
| Q02952 | S248 | Sugiyama | AKAP12 AKAP250 | KESEPKQSTEKPEETLKREQsHAEIsPPAESGQAVEECKEE |
| Q04637 | S1238 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RDAVKREAALPPVsPLKAALsEEELEKKsKAIIEEyLHLND |
| Q04721 | S359 | Sugiyama | NOTCH2 | IDDCAFASCTPGSTCIDRVAsFSCMCPEGKAGLLCHLDDAC |
| Q04726 | S622 | Sugiyama | TLE3 KIAA1547 | VWDLHNQTLVRQFQGHTDGAsCIDISHDGTKLWTGGLDNTV |
| Q04726 | S743 | Sugiyama | TLE3 KIAA1547 | LLNAWRTPYGASIFQSKESSsVLSCDISADDKYIVTGSGDK |
| Q04917 | S64 | Sugiyama | YWHAH YWHA1 | LLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKLEKVKA |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q07021 | S205 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | DCHyPEDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYT |
| Q07157 | S1065 | Sugiyama | TJP1 ZO1 | YVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVP |
| Q08209 | S492 | Sugiyama | PPP3CA CALNA CNA | EAKGLDRINERMPPRRDAMPsDANLNsINKALTSETNGTDS |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09666 | S242 | Sugiyama | AHNAK PM227 | VDIRAGAIsAsGPELQGAGHsKLQVTMPGIKVGGsGVNVNA |
| Q09666 | S5604 | Sugiyama | AHNAK PM227 | GEGHLsVKGsGGEWKGPQVSsALNLDtSKFAGGLHFsGPKV |
| Q12982 | S114 | Sugiyama | BNIP2 NIP2 | EFEWEDDLPKPKTTEVIRKGsItEyTAAEEKEDGRRWRMFR |
| Q13098 | S483 | Sugiyama | GPS1 COPS1 CSN1 | QIHVKsPPREGsQGELtPANsQsRMstNM____________ |
| Q13111 | S777 | Sugiyama | CHAF1A CAF CAF1P150 | FQEHCRRGLLSNHTGSPRSPsTTYLHTPTPSEDAAIPSKSR |
| Q13136 | S668 | Sugiyama | PPFIA1 LIP1 | EEKENTEQRAEEIESRVGsGsLDNLGRFRSMssIPPYPAss |
| Q13162 | S65 | Sugiyama | PRDX4 | RTREEECHFyAGGQVyPGEAsRVsVADHsLHLSKAKISKPA |
| Q13243 | S153 | Sugiyama | SRSF5 HRS SFRS5 SRP40 | EVTFADAHRPKLNEGVVEFAsYGDLKNAIEKLSGKEINGRK |
| Q13263 | S471 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | FGsGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLE |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13283 | S362 | Sugiyama | G3BP1 G3BP | LFIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGF |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13586 | S521 | Sugiyama | STIM1 GOK | QRLTEPQHGLGsQRDLtHsDsEssLHMSDRQRVAPKPPQMS |
| Q13625 | S714 | Sugiyama | TP53BP2 ASPP2 BBP | PRPLsPtKLLPFLSNPYRNQsDADLEALRKKLSNAPRPLKK |
| Q13765 | S117 | Sugiyama | NACA HSD48 | RKSKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQL |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q14126 | S551 | Sugiyama | DSG2 CDHF5 | FSVIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFL |
| Q14157 | S471 | Sugiyama | UBAP2L KIAA0144 NICE4 | PPssPLPsKstsAPQMsPGssDNQsssPQPAQQKLKQQKKK |
| Q14157 | T256 | Sugiyama | UBAP2L KIAA0144 NICE4 | AWRtAtEEWGtEDWNEDLsEtKIFtAsNVssVPLPAENVtI |
| Q14203 | S31 | Sugiyama | DCTN1 | RTPSGSRMsAEASARPLRVGsRVEVIGKGHRGTVAYVGATL |
| Q14257 | S37 | Sugiyama | RCN2 ERC55 | AAAAGAGKAEELHyPLGERRsDyDREALLGVQEDVDEyVKL |
| Q14258 | T341 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | PVYIPEVELNHKLIKGIHQstIDLKNELKQCIGRLQEPTPS |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14966 | S1228 | Sugiyama | ZNF638 NP220 ZFML | DLEKKGAEIINPKTALLPSDsVFAEERNLKGILEEsPsEAE |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q14980 | S1183 | Sugiyama | NUMA1 NMP22 NUMA | ALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQDHS |
| Q15021 | S1333 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | APsAKKPSTGSRyQPLAstAsDNDFVtPEPRRTTRRHPNTQ |
| Q15021 | T586 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | LGLIFKGPAASTQEKNPREstGNMVTGQTVCKNKPNMsDPE |
| Q15075 | S76 | Sugiyama | EEA1 ZFYVE2 | LFKHYEAVHDAGNDsGHGGEsNLALKRDDVTLLRQEVQDLQ |
| Q15084 | S377 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | PAMAAINARKMKFALLKGsFsEQGINEFLRELsFGRGstAP |
| Q15172 | S472 | Sugiyama | PPP2R5A | EELWKKLEELKLKKALEKQNsAyNMHSILSNTSAE______ |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15185 | S82 | Sugiyama | PTGES3 P23 TEBP | NDsKHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVD |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15398 | S789 | Sugiyama | DLGAP5 DLG7 KIAA0008 | EKNTAsQNsILEEGEtKIsQsELFDNKsLttECHLLDsPGL |
| Q15417 | S175 | Sugiyama | CNN3 | GKLKAGQsVIGLQMGTNKCAsQAGMTAyGtRRHLYDPKMQT |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15750 | S339 | Sugiyama | TAB1 MAP3K7IP1 | KQTSLDAVAQAVVDRVKRIHsDTFASGGERARFCPRHEDMT |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16643 | S339 | Sugiyama | DBN1 D0S117E | GsHLDsHRRMAPtPIPtRsPsDsstAstPVAEQIERALDEV |
| Q16695 | S58 | Sugiyama | H3-4 H3FT HIST3H3 | KPHRyRPGtVALREIRRYQKstELLIRKLPFQRLMREIAQD |
| Q16836 | S196 | Sugiyama | HADH HAD HAD1 HADHSC SCHAD | PVMKLVEVIKTPMTSQKTFEsLVDFSKALGKHPVSCKDTPG |
| Q3V6T2 | S1702 | Sugiyama | CCDC88A APE GRDN KIAA1212 | TLQQFLEEsNKLTSVQIKsssQENLLDEVMKSLsVssDFLG |
| Q4V328 | S666 | Sugiyama | GRIPAP1 KIAA1167 | EELVLsEMNsPSRtQtGDsssIssFsYREILREKEssAVPA |
| Q53EL6 | S46 | Sugiyama | PDCD4 H731 | GDEENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKN |
| Q53EL6 | S48 | Sugiyama | PDCD4 H731 | EENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNss |
| Q58FF7 | S405 | Sugiyama | HSP90AB3P HSP90BC | YMTEPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| Q58FF8 | S266 | Sugiyama | HSP90AB2P HSP90BB | EEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWKRDSRV |
| Q58FF8 | S305 | Sugiyama | HSP90AB2P HSP90BB | RVVYMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKR |
| Q5JTV8 | T166 | Sugiyama | TOR1AIP1 LAP1 | MtRRGLRDsHssEEDEAssQtDLsQTISKKtVRsIQEAPVs |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5T1M5 | S1092 | Sugiyama | FKBP15 KIAA0674 | DNPSGKVCVREVAPDGPLQEsstRLsLtsDPEEGDPLALGP |
| Q5TAX3 | S831 | Sugiyama | TUT4 KIAA0191 ZCCHC11 | KLDKKQDDLAPSETCLKKELsQCNCIDLsKsPDPDKSTGTD |
| Q5UIP0 | S1688 | Sugiyama | RIF1 | PVPESNLRTRNAIKRLHKRDsFDNCsLGESSKIGIsDIssL |
| Q5VZL5 | S245 | Sugiyama | ZMYM4 KIAA0425 ZNF262 | SSYPFANKESIGSELGNsFAsNIRIKEEPLDDEYDKAMAPQ |
| Q6DHY5 | T152 | Sugiyama | TBC1D3G | KEKGKRSSEHIQRIDRDISGtLRKHMFFRDRYGTKQRELLH |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6IPX1 | T152 | Sugiyama | TBC1D3C TBC1D3D | KEKGKRSSEHIQRIDRDVSGtLRKHIFFRDRYGTKQRELLH |
| Q6IS14 | S75 | Sugiyama | EIF5AL1 | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQ |
| Q6NXT2 | S57 | Sugiyama | H3-5 H3F3C | KPHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQD |
| Q6P1J9 | S178 | Sugiyama | CDC73 C1orf28 HRPT2 | EGHKEGIVQTEQIRSLsEAMsVEKIAAIKAKIMAKKRSTIK |
| Q6P996 | S722 | Sugiyama | PDXDC1 KIAA0251 | PGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQI |
| Q6PCE3 | S311 | Sugiyama | PGM2L1 BM32A | QKDPDPDFSTVKCPNPEEGEsVLELsLRLAEKENARVVLAT |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6UB35 | S361 | Sugiyama | MTHFD1L FTHFSDC1 | QQHRRWRLHCLKLQPLsPVPsDIEIsRGQTPKAVDVLAKEI |
| Q6UB35 | S366 | Sugiyama | MTHFD1L FTHFSDC1 | WRLHCLKLQPLsPVPsDIEIsRGQTPKAVDVLAKEIGLLAD |
| Q6UX04 | S203 | Sugiyama | CWC27 SDCCAG10 UNQ438/PRO871 | KKEKPEEEVKKLKPKGTKNFsLLsFGEEAEEEEEEVNRVSQ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71DI3 | S58 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | KPHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQD |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q7Z2W4 | S498 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | IADDADPRVALVNDsLsDVtsTtssRVDDHDSEEICLDHLC |
| Q7Z3J3 | S978 | Sugiyama | RGPD4 RGP4 | GRGVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSG |
| Q7Z3J3 | S980 | Sugiyama | RGPD4 RGP4 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| Q7Z3T8 | S360 | Sugiyama | ZFYVE16 KIAA0305 | QSAQEDsKsLDLKDNDVIQDsSsALHVSSKDVPSSLSCLPA |
| Q7Z417 | S608 | Sugiyama | NUFIP2 KIAA1321 PIG1 | sGALsLEPsHIGDLQKADtssQGALVFLSKDYEIEsQNPLA |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z6Z7 | S2535 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | THPLMVRHADHssLtLGsGssttRLtQGIGRsQRTLRQLTA |
| Q7Z7E8 | S401 | Sugiyama | UBE2Q1 NICE5 UBE2Q PRO3094 | KARVQFGANKSQYSLTRAQQsyKsLVQIHEKNGWYtPPKED |
| Q7Z7E8 | S404 | Sugiyama | UBE2Q1 NICE5 UBE2Q PRO3094 | VQFGANKSQYSLTRAQQsyKsLVQIHEKNGWYtPPKEDG__ |
| Q86TC9 | S198 | Sugiyama | MYPN MYOP | CKNHKSKLESQNKVMQENSssFsDLSERRERSSVPIPIPAD |
| Q86TC9 | S200 | Sugiyama | MYPN MYOP | NHKSKLESQNKVMQENSssFsDLSERRERSSVPIPIPADTR |
| Q86TU7 | S505 | Sugiyama | SETD3 C14orf154 | NREYYRQQMEEKAPLPKyEEsNLGLLEssVGDSRLPLVLRN |
| Q86UF2 | S138 | Sugiyama | CTAGE6 CTAGE6P | EKAAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKS |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86V48 | S794 | Sugiyama | LUZP1 | TETTLEKQKPVSKPGPNKVTsSITIYPsDsssPRAAPGEAL |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86W92 | S638 | Sugiyama | PPFIBP1 KIAA1230 | GTRATAGPRLGWsRDLGQsNsDLDMPFAKWTKEQVCNWLME |
| Q8IWW6 | S223 | Sugiyama | ARHGAP12 | GEGSERIHQDSEsGDELSSSsTEQIRAttPPNQGRPDsPVy |
| Q8IWZ3 | S214 | Sugiyama | ANKHD1 KIAA1085 MASK VBARP PP2500 | KAENsHNAGQVDTRsLAEACsDGDVNAVRKLLDEGRSVNEH |
| Q8IX94 | S138 | Sugiyama | CTAGE4 | EKAAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKS |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IYB3 | S240 | Sugiyama | SRRM1 SRM160 | tPELPEPsVKVKEPsVQEAtstsDILKVPKPEPIPEPKEPs |
| Q8N3D4 | S927 | Sugiyama | EHBP1L1 | TQPRVLGSQEAKAEISGVQGsETQVLRVQEAEAGVWGMSEG |
| Q8N6T3 | S345 | Sugiyama | ARFGAP1 ARF1GAP | DQSFWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWE |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NEM2 | S42 | Sugiyama | SHCBP1 | GWAVEQELASLEKGLFQDEDsCsDCsYRDKPGssLQSFMPE |
| Q8NEZ2 | S12 | Sugiyama | VPS37A HCRP1 | _________MSWLFPLTKsAsssAAGsPGGLTSLQQQKQRL |
| Q8NEZ2 | S326 | Sugiyama | VPS37A HCRP1 | QMKSTFEKKMQRQHELSEsCsASALQARLKVAAHEAEEESD |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TDD1 | S624 | Sugiyama | DDX54 | FQQGQQGRQEQQEGPVGPAPsRPALQEKQPEKEEEEEAGEs |
| Q8TEW0 | S840 | Sugiyama | PARD3 PAR3 PAR3A | REGFGRQsMsEKRtKQFsDAsQLDFVKTRKsKsMDLGIADE |
| Q8WUA7 | S145 | Sugiyama | TBC1D22A C22orf4 | RPEAEPPsPPsGDLRLVKsVsEsHtsCPAESASDAAPLQRs |
| Q8WWH5 | S268 | Sugiyama | TRUB1 PUS4 | ECGGGFYIRSLVSDIGKELSsCANVLELTRTKQGPFTLEEH |
| Q8WWI1 | S1510 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RsAsVNKEPVSLPGIMRRGEsLDNLDsPRSNSWRQPPWLNQ |
| Q8WXH0 | T1397 | Sugiyama | SYNE2 KIAA1011 NUA | LDKCLKMLDMSFKDAERGDDtSCENLLDAFSIKLSETHGYG |
| Q8WYP5 | S1343 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | DAPSPEDLEETVFTASKPKsssTALttNVtEQtEKDGDKDV |
| Q92574 | T1047 | Sugiyama | TSC1 KIAA0243 TSC | RGSSGSRGGGGssssssELstPEKPPHQRAGPFSSRWETTM |
| Q92609 | S541 | Sugiyama | TBC1D5 KIAA0210 | EsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssAtK |
| Q92945 | S193 | Sugiyama | KHSRP FUBP2 | DSGCKVQIsPDsGGLPERsVsLtGAPEsVQKAKMMLDDIVS |
| Q93045 | S80 | Sugiyama | STMN2 SCG10 SCGN10 | PPsPISEAPRTLAsPKKKDLsLEEIQKKLEAAEERRKsQEA |
| Q969G3 | S316 | Sugiyama | SMARCE1 BAF57 | ARKRQEEREKEAAEQAERsQssIVPEEEQAANKGEEKKDDE |
| Q96CT7 | S122 | Sugiyama | CCDC124 | DtLRRDHQLREAPDTAEKAKsHLEVPLEENVNRRVLEEGsV |
| Q96D15 | S76 | Sugiyama | RCN3 UNQ239/PRO272 | HEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGDGDGW |
| Q96D15 | S98 | Sugiyama | RCN3 UNQ239/PRO272 | ARLGRIVDRMDRAGDGDGWVsLAELRAWIAHTQQRHIRDsV |
| Q96EP5 | S193 | Sugiyama | DAZAP1 | MHFHDIMGKKVEVKRAEPRDsKsQAPGQPGAsQWGsRVVPN |
| Q96ES7 | S29 | Sugiyama | SGF29 CCDC101 | RIAELLTELHQLIKQTQEERsRsEHNLVNIQKTHERMQTEN |
| Q96ES7 | S31 | Sugiyama | SGF29 CCDC101 | AELLTELHQLIKQTQEERsRsEHNLVNIQKTHERMQTENKI |
| Q96GQ7 | S79 | Sugiyama | DDX27 cPERP-F RHLP HSPC259 PP3241 | EEEEGPIVLGRRQKALGKNRsADFNPDFVFTEKEGTyDGsW |
| Q96HC4 | S362 | Sugiyama | PDLIM5 ENH L9 | SLTAAAAFKPVGStGVIKsPsWQRPNQGVPstGRIsNsAtY |
| Q96IZ0 | Y226 | Sugiyama | PAWR PAR4 | LLDPGSsyLLQEPPRTVSGRyKsttsVsEEDVsSRYsRTDR |
| Q96JH7 | S1077 | Sugiyama | VCPIP1 KIAA1850 VCIP135 | GTDFSNSsTKTEPSVFTASSsNsELIRIAPGVVTMRDGRQL |
| Q96N67 | S1432 | Sugiyama | DOCK7 KIAA1771 | RRSRGQLGTYTIAsPPERsPsGsAFGsQENLRWRKDMTHWR |
| Q96N67 | S1438 | Sugiyama | DOCK7 KIAA1771 | LGTYTIAsPPERsPsGsAFGsQENLRWRKDMTHWRQNTEKL |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q96T88 | S95 | Sugiyama | UHRF1 ICBP90 NP95 RNF106 | QsLVLPHSTKERDsELsDtDsGCCLGQSESDKsstHGEAAA |
| Q99439 | S138 | Sugiyama | CNN2 | TQVQVSLLALAGKAKTKGLQsGVDIGVKYSEKQERNFDDAT |
| Q99439 | S177 | Sugiyama | CNN2 | ATMKAGQCVIGLQMGTNKCAsQSGMTAyGTRRHLYDPKNHI |
| Q99439 | S217 | Sugiyama | CNN2 | ILPPMDHSTISLQMGTNKCAsQVGMTAPGTRRHIyDTKLGT |
| Q99613 | S754 | Sugiyama | EIF3C EIF3S8 | REHVVAASKAMKMGDWKTCHsFIINEKMNGKVWDLFPEADK |
| Q99618 | S94 | Sugiyama | CDCA3 C8 GRCC8 TOME1 | ARtPMKTSsGDPPsPLVKQLsEVFETEDSKSNLPPEPVLPP |
| Q99666 | S977 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | GRGVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSG |
| Q99666 | S979 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| Q99798 | S389 | Sugiyama | ACO2 | EKEGWPLDIRVGLIGSCTNssyEDMGRSAAVAKQALAHGLK |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQS8 | S425 | Sugiyama | FYCO1 ZFYVE7 | EKLQALERERTKVEEVNRQQsAQLEQLVKELQLKEDARASL |
| Q9BTC0 | S975 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | SGVVTTVTVSGRDPRTAPSSsCTAVASAASRPDsTHMVEAR |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BXA7 | S290 | Sugiyama | TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 | CWMQPKARGSPSVAINKEGEsSRGtEPLWtPEPGSDKKSAT |
| Q9BXA7 | T174 | SIGNOR | TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 | DFSFSKRCLRDDSGRMALSKtFCGSPAYAAPEVLQGIPYQP |
| Q9BXA7 | T294 | Sugiyama | TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 | PKARGSPSVAINKEGEsSRGtEPLWtPEPGSDKKSATKLEP |
| Q9BXA7 | T299 | Sugiyama | TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 | SPSVAINKEGEsSRGtEPLWtPEPGSDKKSATKLEPEGEAQ |
| Q9C0C2 | S429 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAA |
| Q9GZV4 | S75 | Sugiyama | EIF5A2 | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDYQLICIQ |
| Q9H2G2 | S340 | Sugiyama | SLK KIAA0204 STK2 | EEDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACIL |
| Q9H2G2 | S341 | Sugiyama | SLK KIAA0204 STK2 | EDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACILE |
| Q9H2G2 | S518 | Sugiyama | SLK KIAA0204 STK2 | tVDLVSQEtGEKEANIQAVDsEVGLTKEDtQEKLGEDDKTQ |
| Q9H3P7 | S316 | Sugiyama | ACBD3 GCP60 GOCAP1 GOLPH1 | QLAQQQAALQKQQEVVVAGssLPtssKVNATVPSNMMSVNG |
| Q9H6S3 | S693 | Sugiyama | EPS8L2 EPS8R2 PP13181 | EGVRVySQLTMQKAFLEKQQsGSELEELMNKFHSMNQRRGE |
| Q9H788 | S118 | Sugiyama | SH2D4A PPP1R38 SH2A | IAERARLKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPD |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9HAU0 | S410 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | NRPNTGPLytEADRVIQRtNsMQQLEQWIKIQKGRGHEEET |
| Q9HCN8 | S40 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | ALLVPGGGAAKTGAELVTCGsVLKLLNTHHRVRLHSHDIKY |
| Q9HD42 | S101 | Sugiyama | CHMP1A CHMP1 KIAA0047 PCOLN3 PRSM1 | TMKGVTKNMAQVTKALDKALsTMDLQKVSSVMDRFEQQVQN |
| Q9NP61 | S457 | Sugiyama | ARFGAP3 ARFGAP1 | sQADYETRARLERLsAsssIssADLFEEPRKQPAGNysLSS |
| Q9NPF0 | S142 | Sugiyama | CD320 8D6A UNQ198/PRO224 | KKLRNCSRLACLAGELRCTLsDDCIPLTWRCDGHPDCPDSS |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NRZ9 | T166 | Sugiyama | HELLS PASG SMARCA6 Nbla10143 | EILSVAKKNKKENEDENssstNLCVEDLQKNKDSNSIIKDR |
| Q9NSV4 | S1119 | Sugiyama | DIAPH3 DIAP3 | PVLKVCNHENQKVQLTEGSRsHYNINCNstRtPVAKELNyN |
| Q9NTJ3 | S504 | Sugiyama | SMC4 CAPC SMC4L1 | ELMGFSKSVNEARSKMDVAQsELDIyLSRHNTAVSQLTKAK |
| Q9NUU7 | S444 | Sugiyama | DDX19A DDX19L | HRIGRTGRFGKRGLAVNMVDsKHSMNILNRIQEHFNKKIER |
| Q9NVN8 | S513 | Sugiyama | GNL3L | PNRHQMGWAKRNVDHRPKsNsMVDVCsVDRRSVLQRIMETD |
| Q9NW68 | S387 | Sugiyama | BSDC1 UNQ2494/PRO5781 | VFELNsDsGKSTPSNNGKKGsstDIsEDWEKDFDLDMTEEE |
| Q9NW82 | S87 | Sugiyama | WDR70 | MNREKELRRQNEDIEPTSSRsNVVRDCSKSSSRDTSSSESE |
| Q9NWS0 | S175 | Sugiyama | PIH1D1 NOP17 | NLQLNPEWRMMKNRPFMGsIsQQNIRSEQRPRIQELGDLyt |
| Q9NXV6 | S175 | Sugiyama | CDKN2AIP CARF | EQDHAKTSAKTERASAQQENsSTCIGsAIKSESGNSARssG |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9NYL9 | S25 | Sugiyama | TMOD3 | FRKDLEKyKDLDEDELLGNLsEtELKQLETVLDDLDPENAL |
| Q9NZ09 | S207 | Sugiyama | UBAP1 NAG20 | TTGPIMAQLLDNNLPRGGsGsVLQDEEVLAsLERATLDFKP |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9NZM1 | S174 | Sugiyama | MYOF FER1L3 KIAA1207 | EDRLDNAVRGPGPKGPVGtVsEAQLARRLtKVKNSRRMLSN |
| Q9P2E9 | S1321 | Sugiyama | RRBP1 KIAA1398 | LEDEQtQRQKLTAEFEEAQTsACRLQEELEKLRTAGPLEsS |
| Q9UBF8 | T426 | Sugiyama | PI4KB PIK4CB | CENFDTTSVPARIPENRIRstRsVENLPECGItHEQRAGSF |
| Q9UGP4 | S667 | Sugiyama | LIMD1 | PLEDHLFCHsCHVKRLEKRPsstALHQHHF___________ |
| Q9UHF7 | S784 | Sugiyama | TRPS1 | VVKREKLEEKDGLKEKVWTEsSSDDLRNVTWRGADILRGsP |
| Q9UHG3 | S447 | Sugiyama | PCYOX1 KIAA0908 PCL1 UNQ597/PRO1183 | YAVKKPWLAYPHYKPPEKCPsIILHDRLYYLNGIECAASAM |
| Q9UHR4 | S354 | Sugiyama | BAIAP2L1 IRTKS | TGLNMMKKQKVKTIFPHtAGsNKTLLSFAQGDVITLLIPEE |
| Q9UHX1 | S461 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | sIsGssARHMVMQKLLRKQEsTVMVLRNMVDPKDIDDDLEG |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UJA5 | S475 | Sugiyama | TRMT6 KIAA1153 TRM6 CGI-09 | SGFTVAMDNLKADtSLKsNAstLESHETEEPAAKKRKCPES |
| Q9ULD2 | S199 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | GKsQsFHtAGSLPPTGRRsGstsSLSySTWTSSHSDKTHAR |
| Q9UMR2 | S445 | Sugiyama | DDX19B DBP5 DDX19 TDBP | HRIGRTGRFGKRGLAVNMVDsKHSMNILNRIQEHFNKKIER |
| Q9UNF1 | T81 | Sugiyama | MAGED2 BCG1 | SGVSKAtEVsKtPEAREAPAtQAssttQLtDtQVLAAENKS |
| Q9UNL2 | S11 | Sugiyama | SSR3 TRAPG | __________MAPKGssKQQsEEDLLLQDFSRNLSAKSSAL |
| Q9UNZ2 | S176 | Sugiyama | NSFL1C UBXN2C | RLGAAPEEEsAyVAGEKRQHssQDVHVVLKLWKsGFsLDNG |
| Q9UPQ0 | S585 | Sugiyama | LIMCH1 KIAA1102 | ETVHREEEKERECPTVAPAHsLtKSQMFEGVARVHGsPLEL |
| Q9UQ35 | S1455 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PsRRsRsGssPGLRDGsGtPsRHsLsGssPGMKDIPRtPSR |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2355 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sANLVGPRsAHAtAPVNIAGsRtAAALAPAsLtsARMAPAL |
| Q9UQ35 | S2459 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | LLPPAQDQPRsPVPsAFsDQsRCLIAQTTPVAGSQSLSSGA |
| Q9UQ35 | S992 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sssPDtKVKPEtPPRQsHsGsIsPyPKVKAQtPPGPsLsGs |
| Q9UQ80 | S41 | Sugiyama | PA2G4 EBP1 | YKMGGDIANRVLRsLVEASssGVsVLsLCEKGDAMIMEEtG |
| Q9UQ80 | S44 | Sugiyama | PA2G4 EBP1 | GGDIANRVLRsLVEASssGVsVLsLCEKGDAMIMEEtGKIF |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S74 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | GsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGE |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
| Q9Y2U5 | S21 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | MDDQQALNSIMQDLAVLHKAsRPALsLQETRKAKSSSPKKQ |
| Q9Y383 | S50 | Sugiyama | LUC7L2 CGI-59 CGI-74 | FSDDRVCKSHLLNCCPHDVLsGTRMDLGECLKVHDLALRAD |
| Q9Y450 | S69 | Sugiyama | HBS1L HBS1 KIAA1038 | sVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDHMR |
| Q9Y490 | S1535 | Sugiyama | TLN1 KIAA1027 TLN | RTTNPTAKRQFVQSAKEVANsTANLVKTIKALDGAFTEENR |
| Q9Y4G6 | S1537 | Sugiyama | TLN2 KIAA0320 | KTANPVAKRHFVQSAKEVANsTANLVKTIKALDGDFSEDNR |
| Q9Y4W2 | S641 | Sugiyama | LAS1L MSTP060 | ENARLLAQKRGALQGsAWQVssEDVRWDTFPLGRMPGQTED |
| Q9Y4X5 | S514 | Sugiyama | ARIH1 ARI MOP6 UBCH7BP HUSSY-27 | NQADLENATEVLSGYLERDIsQDsLQDIKQKVQDKYRYCES |
| Q9Y6Y8 | S894 | Sugiyama | SEC23IP MSTP053 | FISSLKSAWQTLNEFARAHtsstQLQEELEKVANQIKEEEE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.280110e-10 | 9.893 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.334701e-10 | 9.079 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.565316e-09 | 8.448 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.646276e-08 | 7.783 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.699072e-08 | 7.328 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.111867e-07 | 6.675 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.254650e-06 | 5.901 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.530792e-06 | 5.815 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.864249e-06 | 5.729 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.215124e-06 | 5.655 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.240434e-06 | 5.650 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.306460e-06 | 5.275 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.306460e-06 | 5.275 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.857079e-06 | 5.314 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.316113e-06 | 5.031 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.013032e-05 | 4.994 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.041860e-05 | 4.982 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.005734e-05 | 4.698 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.800961e-05 | 4.744 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.759473e-05 | 4.755 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.398914e-05 | 4.620 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.605846e-05 | 4.584 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.810445e-05 | 4.551 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.892889e-05 | 4.539 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.517485e-05 | 4.454 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.216685e-04 | 3.915 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.379686e-04 | 3.860 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.552055e-04 | 3.809 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.722516e-04 | 3.764 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.784759e-04 | 3.748 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.847065e-04 | 3.734 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.101130e-04 | 3.678 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.238144e-04 | 3.650 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.410811e-04 | 3.618 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.508892e-04 | 3.601 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.236236e-04 | 3.490 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.145065e-04 | 3.502 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.203911e-04 | 3.494 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.226290e-04 | 3.491 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.545898e-04 | 3.450 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.148660e-04 | 3.382 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.925084e-04 | 3.406 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.053205e-04 | 3.392 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.930422e-04 | 3.307 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.908185e-04 | 3.309 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.211270e-04 | 3.283 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.572327e-04 | 3.254 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.781481e-04 | 3.238 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.222923e-04 | 3.206 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.780449e-04 | 3.169 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.278863e-04 | 3.138 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.278863e-04 | 3.138 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.323483e-04 | 3.080 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.631152e-04 | 3.064 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.503069e-04 | 3.070 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.837833e-04 | 3.007 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.088676e-03 | 2.963 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.137136e-03 | 2.944 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.185236e-03 | 2.926 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.281212e-03 | 2.892 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.471514e-03 | 2.832 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.540466e-03 | 2.812 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.914340e-03 | 2.718 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.940173e-03 | 2.712 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.157594e-03 | 2.666 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.159495e-03 | 2.666 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.168576e-03 | 2.664 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.348861e-03 | 2.629 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.348861e-03 | 2.629 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.284325e-03 | 2.641 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.383334e-03 | 2.623 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.406852e-03 | 2.619 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.511935e-03 | 2.600 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.511935e-03 | 2.600 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.890658e-03 | 2.539 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.082231e-03 | 2.511 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.138995e-03 | 2.503 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.246517e-03 | 2.489 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.457150e-03 | 2.461 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.457150e-03 | 2.461 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.457150e-03 | 2.461 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.457150e-03 | 2.461 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.457150e-03 | 2.461 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.449082e-03 | 2.462 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.608399e-03 | 2.443 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.800413e-03 | 2.420 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.846039e-03 | 2.415 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.846039e-03 | 2.415 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.009717e-03 | 2.397 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.013638e-03 | 2.396 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.946509e-03 | 2.404 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.090764e-03 | 2.388 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.170644e-03 | 2.380 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.407600e-03 | 2.356 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.407600e-03 | 2.356 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.407600e-03 | 2.356 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.407600e-03 | 2.356 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.477889e-03 | 2.349 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.390624e-03 | 2.357 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.500660e-03 | 2.347 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.538170e-03 | 2.343 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.602571e-03 | 2.337 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.003781e-03 | 2.301 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.003781e-03 | 2.301 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.090854e-03 | 2.293 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.092247e-03 | 2.293 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.049538e-03 | 2.218 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.049538e-03 | 2.218 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.049538e-03 | 2.218 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.049538e-03 | 2.218 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.103990e-03 | 2.214 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.371139e-03 | 2.196 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.371139e-03 | 2.196 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.847926e-03 | 2.164 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.782764e-03 | 2.169 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.171193e-03 | 2.144 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.581324e-03 | 2.120 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.629254e-03 | 2.118 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.830996e-03 | 2.106 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.830996e-03 | 2.106 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.296178e-03 | 2.081 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.404635e-03 | 2.075 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.719595e-03 | 2.060 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.077981e-03 | 2.042 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.032383e-03 | 2.044 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.634784e-03 | 2.064 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.213460e-03 | 2.036 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 9.278990e-03 | 2.032 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 9.347376e-03 | 2.029 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.383898e-03 | 2.028 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.025323e-02 | 1.989 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.023858e-02 | 1.990 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.023858e-02 | 1.990 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.023858e-02 | 1.990 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.006103e-02 | 1.997 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.057301e-02 | 1.976 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.067099e-02 | 1.972 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.083153e-02 | 1.965 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.110849e-02 | 1.954 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.195102e-02 | 1.923 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.196303e-02 | 1.922 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.196303e-02 | 1.922 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.208593e-02 | 1.918 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.267808e-02 | 1.897 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.329270e-02 | 1.876 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.219162e-02 | 1.914 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.221529e-02 | 1.913 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.240774e-02 | 1.906 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.260164e-02 | 1.900 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.338295e-02 | 1.873 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.343651e-02 | 1.872 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.346526e-02 | 1.871 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.374598e-02 | 1.862 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.374598e-02 | 1.862 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.374598e-02 | 1.862 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.374598e-02 | 1.862 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.381589e-02 | 1.860 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.476002e-02 | 1.831 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.471484e-02 | 1.832 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.519956e-02 | 1.818 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.476002e-02 | 1.831 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.523553e-02 | 1.817 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.491613e-02 | 1.826 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.428091e-02 | 1.845 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.523553e-02 | 1.817 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.413336e-02 | 1.850 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.531212e-02 | 1.815 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.532904e-02 | 1.814 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.579274e-02 | 1.802 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.579274e-02 | 1.802 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.598637e-02 | 1.796 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.917004e-02 | 1.717 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.620557e-02 | 1.790 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.698694e-02 | 1.770 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.014648e-02 | 1.696 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.011580e-02 | 1.696 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.954260e-02 | 1.709 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.986924e-02 | 1.702 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.832303e-02 | 1.737 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.025479e-02 | 1.693 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.719912e-02 | 1.764 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.770677e-02 | 1.752 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.863532e-02 | 1.730 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.665910e-02 | 1.778 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.665910e-02 | 1.778 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.026783e-02 | 1.693 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.057381e-02 | 1.687 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.085253e-02 | 1.681 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.103541e-02 | 1.677 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.158662e-02 | 1.666 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.184691e-02 | 1.661 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.210942e-02 | 1.655 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.234811e-02 | 1.651 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.286370e-02 | 1.641 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.350606e-02 | 1.629 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.350606e-02 | 1.629 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.350606e-02 | 1.629 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.350606e-02 | 1.629 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.350606e-02 | 1.629 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.350606e-02 | 1.629 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.350606e-02 | 1.629 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.350606e-02 | 1.629 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.350606e-02 | 1.629 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.350606e-02 | 1.629 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.350606e-02 | 1.629 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.366354e-02 | 1.626 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.366354e-02 | 1.626 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.461650e-02 | 1.609 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.619636e-02 | 1.582 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.603393e-02 | 1.584 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.366354e-02 | 1.626 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.303865e-02 | 1.638 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.545347e-02 | 1.594 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.696168e-02 | 1.569 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.717077e-02 | 1.566 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.717077e-02 | 1.566 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.769865e-02 | 1.558 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.769865e-02 | 1.558 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.808781e-02 | 1.551 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.808781e-02 | 1.551 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.808781e-02 | 1.551 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.870287e-02 | 1.542 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.880732e-02 | 1.540 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.885163e-02 | 1.540 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.886086e-02 | 1.540 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.946200e-02 | 1.531 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.951752e-02 | 1.530 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.099083e-02 | 1.509 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.174006e-02 | 1.498 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.257523e-02 | 1.487 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 3.738456e-02 | 1.427 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.659255e-02 | 1.437 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.876104e-02 | 1.412 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.876104e-02 | 1.412 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.876104e-02 | 1.412 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.876104e-02 | 1.412 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.480896e-02 | 1.458 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.805498e-02 | 1.420 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.805498e-02 | 1.420 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.349104e-02 | 1.475 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.869382e-02 | 1.412 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.504652e-02 | 1.455 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.777469e-02 | 1.423 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.446017e-02 | 1.463 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.805498e-02 | 1.420 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.406909e-02 | 1.468 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.444749e-02 | 1.463 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.876104e-02 | 1.412 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.876104e-02 | 1.412 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.422971e-02 | 1.466 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.682571e-02 | 1.434 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.874864e-02 | 1.412 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.805498e-02 | 1.420 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.395098e-02 | 1.469 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.953743e-02 | 1.403 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.981976e-02 | 1.400 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.136013e-02 | 1.383 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.136013e-02 | 1.383 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.137884e-02 | 1.383 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.154956e-02 | 1.381 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.230527e-02 | 1.374 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.274971e-02 | 1.369 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.274971e-02 | 1.369 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.318928e-02 | 1.365 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.324115e-02 | 1.364 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.331474e-02 | 1.363 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.413346e-02 | 1.355 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.431389e-02 | 1.353 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.468745e-02 | 1.350 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.658929e-02 | 1.332 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.658929e-02 | 1.332 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.694792e-02 | 1.328 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.709780e-02 | 1.327 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.911832e-02 | 1.309 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.933638e-02 | 1.307 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.933638e-02 | 1.307 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.037668e-02 | 1.298 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.042053e-02 | 1.297 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.103716e-02 | 1.292 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.114743e-02 | 1.291 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.137920e-02 | 1.289 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.235206e-02 | 1.281 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.313822e-02 | 1.200 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.313822e-02 | 1.200 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.821432e-02 | 1.235 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.721254e-02 | 1.243 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.821432e-02 | 1.235 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.448172e-02 | 1.264 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.313822e-02 | 1.200 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.670152e-02 | 1.246 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.396796e-02 | 1.268 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.396796e-02 | 1.268 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.795759e-02 | 1.237 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.448172e-02 | 1.264 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.313822e-02 | 1.200 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.642868e-02 | 1.249 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.369510e-02 | 1.196 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.384233e-02 | 1.195 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.669299e-02 | 1.176 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.669299e-02 | 1.176 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.684880e-02 | 1.175 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.684880e-02 | 1.175 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.688035e-02 | 1.175 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.688035e-02 | 1.175 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.688035e-02 | 1.175 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.689992e-02 | 1.175 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.689992e-02 | 1.175 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.805111e-02 | 1.167 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.122386e-02 | 1.147 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.122386e-02 | 1.147 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.122386e-02 | 1.147 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.122386e-02 | 1.147 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.122386e-02 | 1.147 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.149091e-02 | 1.146 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.245060e-02 | 1.140 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.323961e-02 | 1.135 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.323961e-02 | 1.135 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.385818e-02 | 1.132 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.498079e-02 | 1.125 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 7.631086e-02 | 1.117 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 7.631086e-02 | 1.117 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 7.631086e-02 | 1.117 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.632004e-02 | 1.117 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.632004e-02 | 1.117 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.632004e-02 | 1.117 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.632004e-02 | 1.117 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.633244e-02 | 1.117 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.661950e-02 | 1.116 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.661950e-02 | 1.116 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.836556e-02 | 1.106 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 7.966758e-02 | 1.099 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.966758e-02 | 1.099 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.966758e-02 | 1.099 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 9.107694e-02 | 1.041 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 9.107694e-02 | 1.041 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 9.107694e-02 | 1.041 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.030113e-01 | 0.987 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.895480e-02 | 1.051 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.021153e-01 | 0.991 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.814279e-02 | 1.055 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.751515e-02 | 1.011 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.751515e-02 | 1.011 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.800861e-02 | 1.055 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.467793e-02 | 1.072 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.467793e-02 | 1.072 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.109982e-02 | 1.040 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.949739e-02 | 1.002 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.440043e-02 | 1.074 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.927705e-02 | 1.049 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.008364e-01 | 0.996 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.020738e-01 | 0.991 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.120010e-02 | 1.040 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.131251e-02 | 1.039 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.974194e-02 | 1.047 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.760092e-02 | 1.057 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.029686e-01 | 0.987 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.602699e-02 | 1.065 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.847515e-02 | 1.053 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.052720e-01 | 0.978 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.058949e-01 | 0.975 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.059197e-01 | 0.975 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.067636e-01 | 0.972 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.095378e-01 | 0.960 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.100997e-01 | 0.958 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.105812e-01 | 0.956 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.106264e-01 | 0.956 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.106264e-01 | 0.956 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.106264e-01 | 0.956 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.106264e-01 | 0.956 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.106264e-01 | 0.956 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.106264e-01 | 0.956 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.118899e-01 | 0.951 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.118899e-01 | 0.951 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.119706e-01 | 0.951 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.127453e-01 | 0.948 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.161869e-01 | 0.935 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.161869e-01 | 0.935 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.163005e-01 | 0.934 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.163005e-01 | 0.934 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.168373e-01 | 0.932 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.170817e-01 | 0.932 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.401802e-01 | 0.853 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.401802e-01 | 0.853 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.401802e-01 | 0.853 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.401802e-01 | 0.853 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.401802e-01 | 0.853 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.232407e-01 | 0.909 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.232407e-01 | 0.909 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.222579e-01 | 0.913 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 1.222579e-01 | 0.913 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.222579e-01 | 0.913 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.222579e-01 | 0.913 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.222579e-01 | 0.913 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.222579e-01 | 0.913 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.567001e-01 | 0.805 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.567001e-01 | 0.805 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.567001e-01 | 0.805 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.362523e-01 | 0.866 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.362523e-01 | 0.866 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.179117e-01 | 0.928 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.179117e-01 | 0.928 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.179117e-01 | 0.928 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.179117e-01 | 0.928 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.197192e-01 | 0.922 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.387795e-01 | 0.858 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.387795e-01 | 0.858 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.356676e-01 | 0.868 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.314825e-01 | 0.881 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.314825e-01 | 0.881 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.314825e-01 | 0.881 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.267705e-01 | 0.897 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.476240e-01 | 0.831 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.413687e-01 | 0.850 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.491641e-01 | 0.826 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.283523e-01 | 0.892 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.553795e-01 | 0.809 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.444301e-01 | 0.840 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.522890e-01 | 0.817 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.403536e-01 | 0.853 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.536858e-01 | 0.813 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.362523e-01 | 0.866 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.362523e-01 | 0.866 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.395780e-01 | 0.855 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.397498e-01 | 0.855 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.446731e-01 | 0.840 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.473668e-01 | 0.832 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.192656e-01 | 0.923 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.387795e-01 | 0.858 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.501091e-01 | 0.824 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.387795e-01 | 0.858 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.290241e-01 | 0.889 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.491458e-01 | 0.826 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.314825e-01 | 0.881 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.507457e-01 | 0.822 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.222579e-01 | 0.913 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.441112e-01 | 0.841 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 1.232407e-01 | 0.909 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.222579e-01 | 0.913 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.567001e-01 | 0.805 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.179117e-01 | 0.928 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.267705e-01 | 0.897 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.555437e-01 | 0.808 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.187570e-01 | 0.925 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.282626e-01 | 0.892 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.414772e-01 | 0.849 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.237441e-01 | 0.907 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.413687e-01 | 0.850 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.446731e-01 | 0.840 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.231102e-01 | 0.910 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.387795e-01 | 0.858 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.353232e-01 | 0.869 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.422116e-01 | 0.847 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.567813e-01 | 0.805 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.573298e-01 | 0.803 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.573354e-01 | 0.803 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.607168e-01 | 0.584 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.607168e-01 | 0.584 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.607168e-01 | 0.584 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.607168e-01 | 0.584 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.607168e-01 | 0.584 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.607168e-01 | 0.584 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.607168e-01 | 0.584 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.607168e-01 | 0.584 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.607168e-01 | 0.584 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.607168e-01 | 0.584 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.607168e-01 | 0.584 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.607168e-01 | 0.584 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.751671e-01 | 0.757 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.751671e-01 | 0.757 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.297684e-01 | 0.639 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.297684e-01 | 0.639 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.297684e-01 | 0.639 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.643616e-01 | 0.438 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.643616e-01 | 0.438 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.643616e-01 | 0.438 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.643616e-01 | 0.438 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.643616e-01 | 0.438 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.643616e-01 | 0.438 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.643616e-01 | 0.438 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.643616e-01 | 0.438 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.643616e-01 | 0.438 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.643616e-01 | 0.438 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.643616e-01 | 0.438 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.643616e-01 | 0.438 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.643616e-01 | 0.438 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.643616e-01 | 0.438 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.643616e-01 | 0.438 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.643616e-01 | 0.438 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.643616e-01 | 0.438 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.643616e-01 | 0.438 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.643616e-01 | 0.438 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.936991e-01 | 0.713 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.936991e-01 | 0.713 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.936991e-01 | 0.713 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.936991e-01 | 0.713 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.936991e-01 | 0.713 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.936991e-01 | 0.713 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.936991e-01 | 0.713 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.640118e-01 | 0.785 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.852751e-01 | 0.545 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.852751e-01 | 0.545 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.852751e-01 | 0.545 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.852751e-01 | 0.545 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.852751e-01 | 0.545 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.325685e-01 | 0.633 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.325685e-01 | 0.633 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.325685e-01 | 0.633 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.325685e-01 | 0.633 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.325685e-01 | 0.633 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.325685e-01 | 0.633 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.935906e-01 | 0.713 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.632035e-01 | 0.787 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.591511e-01 | 0.798 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.880994e-01 | 0.726 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.246602e-01 | 0.648 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.246602e-01 | 0.648 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.246602e-01 | 0.648 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.726650e-01 | 0.564 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 2.726650e-01 | 0.564 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.726650e-01 | 0.564 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.726650e-01 | 0.564 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.726650e-01 | 0.564 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.403611e-01 | 0.468 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.403611e-01 | 0.468 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.403611e-01 | 0.468 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.403611e-01 | 0.468 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.403611e-01 | 0.468 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.403611e-01 | 0.468 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.403611e-01 | 0.468 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.534809e-01 | 0.343 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.534809e-01 | 0.343 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.534809e-01 | 0.343 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.534809e-01 | 0.343 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.534809e-01 | 0.343 | 0 | 0 |
| Essential pentosuria | R-HSA-5662853 | 4.534809e-01 | 0.343 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.534809e-01 | 0.343 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.534809e-01 | 0.343 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.534809e-01 | 0.343 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.534809e-01 | 0.343 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.142492e-01 | 0.669 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.142492e-01 | 0.669 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.568899e-01 | 0.590 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.134035e-01 | 0.504 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.134035e-01 | 0.504 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.134035e-01 | 0.504 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.646788e-01 | 0.783 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.414554e-01 | 0.617 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.414554e-01 | 0.617 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.414554e-01 | 0.617 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.825927e-01 | 0.739 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.270131e-01 | 0.644 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.899557e-01 | 0.538 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.899557e-01 | 0.538 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.899557e-01 | 0.538 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 2.899557e-01 | 0.538 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.899557e-01 | 0.538 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.940537e-01 | 0.404 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.940537e-01 | 0.404 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 3.940537e-01 | 0.404 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.729705e-01 | 0.762 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.639048e-01 | 0.785 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.514593e-01 | 0.600 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.542658e-01 | 0.451 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.542658e-01 | 0.451 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.542658e-01 | 0.451 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.793211e-01 | 0.746 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.793211e-01 | 0.746 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.793211e-01 | 0.746 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.793211e-01 | 0.746 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.353165e-01 | 0.628 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.207472e-01 | 0.656 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.235478e-01 | 0.490 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.235478e-01 | 0.490 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.074985e-01 | 0.683 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.842311e-01 | 0.735 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.842311e-01 | 0.735 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.644049e-01 | 0.784 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.408489e-01 | 0.618 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.995239e-01 | 0.700 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.805933e-01 | 0.552 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.805933e-01 | 0.552 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.805933e-01 | 0.552 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.022704e-01 | 0.520 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.274016e-01 | 0.485 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.573761e-01 | 0.447 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.948030e-01 | 0.404 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.948030e-01 | 0.404 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.948030e-01 | 0.404 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.948030e-01 | 0.404 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.948030e-01 | 0.404 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 3.948030e-01 | 0.404 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.456614e-01 | 0.351 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.456614e-01 | 0.351 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.456614e-01 | 0.351 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.456614e-01 | 0.351 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 4.456614e-01 | 0.351 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 4.456614e-01 | 0.351 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.456614e-01 | 0.351 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.456614e-01 | 0.351 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.630946e-01 | 0.788 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.177566e-01 | 0.662 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.647481e-01 | 0.783 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.950244e-01 | 0.710 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.039966e-01 | 0.517 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.283569e-01 | 0.484 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.283569e-01 | 0.484 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.283569e-01 | 0.484 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.568385e-01 | 0.448 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.568385e-01 | 0.448 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.343232e-01 | 0.630 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.911738e-01 | 0.408 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.911738e-01 | 0.408 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.656594e-01 | 0.576 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.495719e-01 | 0.603 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.982559e-01 | 0.703 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.037957e-01 | 0.517 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.346356e-01 | 0.362 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.346356e-01 | 0.362 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.346356e-01 | 0.362 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.346356e-01 | 0.362 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.832343e-01 | 0.548 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.262943e-01 | 0.486 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.262943e-01 | 0.486 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.242733e-01 | 0.489 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.200934e-01 | 0.657 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.485135e-01 | 0.458 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.812142e-01 | 0.419 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.812142e-01 | 0.419 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.812142e-01 | 0.419 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.247001e-01 | 0.372 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.247001e-01 | 0.372 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.193284e-01 | 0.496 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.626237e-01 | 0.789 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.528057e-01 | 0.597 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.528057e-01 | 0.597 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.077283e-01 | 0.390 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.077283e-01 | 0.390 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.077283e-01 | 0.390 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.077283e-01 | 0.390 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.077283e-01 | 0.390 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.077283e-01 | 0.390 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.734499e-01 | 0.325 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.734499e-01 | 0.325 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.577416e-01 | 0.339 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.338648e-01 | 0.631 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.341395e-01 | 0.362 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.245671e-01 | 0.372 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.704261e-01 | 0.431 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.462914e-01 | 0.461 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.207310e-01 | 0.376 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.603374e-01 | 0.337 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.608102e-01 | 0.336 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.334605e-01 | 0.363 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.507566e-01 | 0.346 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.507566e-01 | 0.346 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.507566e-01 | 0.346 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.507566e-01 | 0.346 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.507566e-01 | 0.346 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.349274e-01 | 0.362 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.493397e-01 | 0.347 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.493397e-01 | 0.347 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.546151e-01 | 0.450 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.343232e-01 | 0.630 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.701696e-01 | 0.769 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.194601e-01 | 0.659 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.080667e-01 | 0.682 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.982309e-01 | 0.525 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.760617e-01 | 0.754 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.039966e-01 | 0.517 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 2.325685e-01 | 0.633 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.807278e-01 | 0.743 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.092936e-01 | 0.510 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.257347e-01 | 0.646 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.697298e-01 | 0.432 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.591511e-01 | 0.798 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.610786e-01 | 0.442 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.726449e-01 | 0.763 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.473931e-01 | 0.459 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.694385e-01 | 0.771 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.694385e-01 | 0.771 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.705389e-01 | 0.568 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.805484e-01 | 0.420 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.936991e-01 | 0.713 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.246602e-01 | 0.648 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.573761e-01 | 0.447 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.911738e-01 | 0.408 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.247001e-01 | 0.372 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.610786e-01 | 0.442 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.695164e-01 | 0.569 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.694385e-01 | 0.771 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.346356e-01 | 0.362 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.948030e-01 | 0.404 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.911738e-01 | 0.408 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.159518e-01 | 0.381 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.591511e-01 | 0.798 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.514593e-01 | 0.600 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.235478e-01 | 0.490 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.568385e-01 | 0.448 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.213297e-01 | 0.655 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.170040e-01 | 0.380 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.568899e-01 | 0.590 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.578461e-01 | 0.589 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.804377e-01 | 0.744 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.142528e-01 | 0.503 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.542658e-01 | 0.451 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.134035e-01 | 0.504 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.805933e-01 | 0.552 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.603374e-01 | 0.337 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.827234e-01 | 0.549 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.245671e-01 | 0.372 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.841787e-01 | 0.735 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.750216e-01 | 0.426 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.603734e-01 | 0.795 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.603734e-01 | 0.795 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.408489e-01 | 0.618 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.297684e-01 | 0.639 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.726650e-01 | 0.564 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.403611e-01 | 0.468 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.134035e-01 | 0.504 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.414554e-01 | 0.617 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.456614e-01 | 0.351 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.088310e-01 | 0.680 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.485135e-01 | 0.458 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.159518e-01 | 0.381 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.384386e-01 | 0.358 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.959674e-01 | 0.402 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.608102e-01 | 0.336 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.507579e-01 | 0.346 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.774600e-01 | 0.751 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.039966e-01 | 0.517 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.348902e-01 | 0.629 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.995239e-01 | 0.700 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.591511e-01 | 0.798 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.615339e-01 | 0.582 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.984169e-01 | 0.702 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.858635e-01 | 0.544 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.562191e-01 | 0.591 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.297684e-01 | 0.639 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.852751e-01 | 0.545 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.325685e-01 | 0.633 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.935906e-01 | 0.713 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.246602e-01 | 0.648 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.793211e-01 | 0.746 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.573761e-01 | 0.447 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.346356e-01 | 0.362 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.262943e-01 | 0.486 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.622076e-01 | 0.581 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.812142e-01 | 0.419 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 4.734499e-01 | 0.325 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.577416e-01 | 0.339 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.695811e-01 | 0.328 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.937527e-01 | 0.532 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.592393e-01 | 0.798 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.685615e-01 | 0.773 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.685615e-01 | 0.773 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.573761e-01 | 0.447 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.408489e-01 | 0.618 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.934195e-01 | 0.405 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.643583e-01 | 0.578 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.703004e-01 | 0.769 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.727425e-01 | 0.763 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.094720e-01 | 0.679 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.136482e-01 | 0.670 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.487140e-01 | 0.348 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.644118e-01 | 0.578 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.325685e-01 | 0.633 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.644049e-01 | 0.784 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.213297e-01 | 0.655 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.346356e-01 | 0.362 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 4.247001e-01 | 0.372 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.282762e-01 | 0.368 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.610368e-01 | 0.793 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.736157e-01 | 0.428 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.647893e-01 | 0.333 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.638661e-01 | 0.579 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.413985e-01 | 0.467 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.207310e-01 | 0.376 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.568740e-01 | 0.340 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.751671e-01 | 0.757 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.403611e-01 | 0.468 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.534809e-01 | 0.343 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.568899e-01 | 0.590 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.899557e-01 | 0.538 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.408489e-01 | 0.618 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.247001e-01 | 0.372 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.738321e-01 | 0.324 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.713178e-01 | 0.327 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.747177e-01 | 0.324 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.969677e-01 | 0.706 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.594277e-01 | 0.444 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.469618e-01 | 0.607 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.408489e-01 | 0.618 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.262943e-01 | 0.486 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.899557e-01 | 0.538 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.573761e-01 | 0.447 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.762075e-01 | 0.559 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.872087e-01 | 0.728 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.450053e-01 | 0.462 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.504529e-01 | 0.346 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.953769e-01 | 0.709 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.754479e-01 | 0.756 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.751671e-01 | 0.757 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 3.134035e-01 | 0.504 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.542658e-01 | 0.451 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.948030e-01 | 0.404 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.343232e-01 | 0.630 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 1.984169e-01 | 0.702 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.450063e-01 | 0.352 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.245671e-01 | 0.372 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.976339e-01 | 0.401 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.153509e-01 | 0.667 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.855034e-01 | 0.732 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.554006e-01 | 0.449 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.269300e-01 | 0.486 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.033911e-01 | 0.692 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.760264e-01 | 0.425 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.694385e-01 | 0.771 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.932855e-01 | 0.714 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.932855e-01 | 0.714 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.291837e-01 | 0.367 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.291837e-01 | 0.367 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.257347e-01 | 0.646 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.603374e-01 | 0.337 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.475466e-01 | 0.606 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.808442e-01 | 0.552 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.932855e-01 | 0.714 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.185637e-01 | 0.660 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.805933e-01 | 0.552 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.834541e-01 | 0.548 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.413985e-01 | 0.467 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.445441e-01 | 0.612 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.800341e-01 | 0.553 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.384386e-01 | 0.358 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.607168e-01 | 0.584 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.751671e-01 | 0.757 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.751671e-01 | 0.757 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.643616e-01 | 0.438 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.936991e-01 | 0.713 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.936991e-01 | 0.713 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 1.936991e-01 | 0.713 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.852751e-01 | 0.545 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.534809e-01 | 0.343 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 4.534809e-01 | 0.343 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.534809e-01 | 0.343 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.534809e-01 | 0.343 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.534809e-01 | 0.343 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.568899e-01 | 0.590 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.676656e-01 | 0.776 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.573761e-01 | 0.447 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.923880e-01 | 0.716 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.048874e-01 | 0.393 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.726658e-01 | 0.325 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.760264e-01 | 0.425 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.037957e-01 | 0.517 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.262943e-01 | 0.486 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.193284e-01 | 0.496 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.594277e-01 | 0.444 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.353357e-01 | 0.628 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.274016e-01 | 0.485 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.924246e-01 | 0.406 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.245671e-01 | 0.372 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.423202e-01 | 0.354 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.644373e-01 | 0.438 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.812142e-01 | 0.419 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.487140e-01 | 0.348 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.940537e-01 | 0.404 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 3.542658e-01 | 0.451 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.456614e-01 | 0.351 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.951775e-01 | 0.530 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.080777e-01 | 0.389 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.161463e-01 | 0.381 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.610786e-01 | 0.442 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.283569e-01 | 0.484 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.215708e-01 | 0.375 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.982309e-01 | 0.525 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.638661e-01 | 0.579 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.269522e-01 | 0.370 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.568385e-01 | 0.448 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.734499e-01 | 0.325 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.534809e-01 | 0.343 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.134035e-01 | 0.504 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.346356e-01 | 0.362 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.734499e-01 | 0.325 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.341395e-01 | 0.362 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.217042e-01 | 0.375 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.711611e-01 | 0.327 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.423202e-01 | 0.354 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.734499e-01 | 0.325 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.734499e-01 | 0.325 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.869714e-01 | 0.412 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.056612e-01 | 0.392 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.597562e-01 | 0.585 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.534809e-01 | 0.343 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.456614e-01 | 0.351 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.827234e-01 | 0.549 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.751415e-01 | 0.426 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.604909e-01 | 0.337 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.695164e-01 | 0.569 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.095909e-01 | 0.679 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.855034e-01 | 0.732 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.711611e-01 | 0.327 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.247001e-01 | 0.372 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.082679e-01 | 0.511 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.852751e-01 | 0.545 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.726650e-01 | 0.564 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.726650e-01 | 0.564 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.403611e-01 | 0.468 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.456614e-01 | 0.351 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.450053e-01 | 0.462 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.450053e-01 | 0.462 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.729705e-01 | 0.762 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.651761e-01 | 0.576 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.982206e-01 | 0.703 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.825927e-01 | 0.739 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.755051e-01 | 0.323 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.776547e-01 | 0.321 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.777497e-01 | 0.321 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.830008e-01 | 0.316 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.830008e-01 | 0.316 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.830008e-01 | 0.316 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.856938e-01 | 0.314 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.862207e-01 | 0.313 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.862207e-01 | 0.313 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.901124e-01 | 0.310 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.901124e-01 | 0.310 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.901124e-01 | 0.310 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.947135e-01 | 0.306 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.947135e-01 | 0.306 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.947135e-01 | 0.306 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.947135e-01 | 0.306 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.947135e-01 | 0.306 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.947135e-01 | 0.306 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.947135e-01 | 0.306 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.947135e-01 | 0.306 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.963451e-01 | 0.304 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.963451e-01 | 0.304 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.997925e-01 | 0.301 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.021541e-01 | 0.299 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.021541e-01 | 0.299 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.021541e-01 | 0.299 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.021541e-01 | 0.299 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.022340e-01 | 0.299 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.049490e-01 | 0.297 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.068511e-01 | 0.295 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.109943e-01 | 0.292 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.109943e-01 | 0.292 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.109943e-01 | 0.292 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.109943e-01 | 0.292 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.109943e-01 | 0.292 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.109943e-01 | 0.292 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.109943e-01 | 0.292 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 5.109943e-01 | 0.292 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.124639e-01 | 0.290 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.127980e-01 | 0.290 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.148310e-01 | 0.288 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.169960e-01 | 0.287 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.191545e-01 | 0.285 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.191614e-01 | 0.285 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.191614e-01 | 0.285 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.193786e-01 | 0.285 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.196805e-01 | 0.284 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.216537e-01 | 0.283 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.216537e-01 | 0.283 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.216537e-01 | 0.283 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 5.216537e-01 | 0.283 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.252227e-01 | 0.280 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.265975e-01 | 0.279 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.265975e-01 | 0.279 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.265975e-01 | 0.279 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.298613e-01 | 0.276 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.298613e-01 | 0.276 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.298613e-01 | 0.276 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.298613e-01 | 0.276 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.298613e-01 | 0.276 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 5.301097e-01 | 0.276 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.301097e-01 | 0.276 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.301097e-01 | 0.276 | 0 | 0 |
| Phenylketonuria | R-HSA-2160456 | 5.301097e-01 | 0.276 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.301097e-01 | 0.276 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.301097e-01 | 0.276 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 5.301097e-01 | 0.276 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.301097e-01 | 0.276 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.301097e-01 | 0.276 | 0 | 0 |
| Defective CYP7B1 causes SPG5A and CBAS3 | R-HSA-5579013 | 5.301097e-01 | 0.276 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.301097e-01 | 0.276 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.301097e-01 | 0.276 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.301097e-01 | 0.276 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.301097e-01 | 0.276 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 5.301097e-01 | 0.276 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.307746e-01 | 0.275 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.307746e-01 | 0.275 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.366838e-01 | 0.270 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.366838e-01 | 0.270 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.366838e-01 | 0.270 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.378257e-01 | 0.269 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.409122e-01 | 0.267 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.409122e-01 | 0.267 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.409122e-01 | 0.267 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.409122e-01 | 0.267 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.409122e-01 | 0.267 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.409122e-01 | 0.267 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.409122e-01 | 0.267 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.409122e-01 | 0.267 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 5.409122e-01 | 0.267 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.409122e-01 | 0.267 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.409122e-01 | 0.267 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.409122e-01 | 0.267 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.426073e-01 | 0.266 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.433729e-01 | 0.265 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.451866e-01 | 0.263 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.470730e-01 | 0.262 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.470730e-01 | 0.262 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.470730e-01 | 0.262 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.470730e-01 | 0.262 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.470730e-01 | 0.262 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.470730e-01 | 0.262 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.470730e-01 | 0.262 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.470730e-01 | 0.262 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.478942e-01 | 0.261 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.478942e-01 | 0.261 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.478942e-01 | 0.261 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.478942e-01 | 0.261 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.478942e-01 | 0.261 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.510080e-01 | 0.259 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.522332e-01 | 0.258 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.527032e-01 | 0.258 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.527032e-01 | 0.258 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.568576e-01 | 0.254 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.568576e-01 | 0.254 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.568576e-01 | 0.254 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.571380e-01 | 0.254 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.611073e-01 | 0.251 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.611073e-01 | 0.251 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.611073e-01 | 0.251 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.639399e-01 | 0.249 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.650671e-01 | 0.248 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.650671e-01 | 0.248 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.651514e-01 | 0.248 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.687912e-01 | 0.245 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.688206e-01 | 0.245 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.688206e-01 | 0.245 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.703034e-01 | 0.244 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.710069e-01 | 0.243 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.714528e-01 | 0.243 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.788851e-01 | 0.237 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.800717e-01 | 0.237 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.815404e-01 | 0.235 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.815404e-01 | 0.235 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.815404e-01 | 0.235 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.815404e-01 | 0.235 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.815404e-01 | 0.235 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.815404e-01 | 0.235 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.817433e-01 | 0.235 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.817433e-01 | 0.235 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.817433e-01 | 0.235 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.830618e-01 | 0.234 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.830618e-01 | 0.234 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.840934e-01 | 0.234 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.840934e-01 | 0.234 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 5.840934e-01 | 0.234 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.840934e-01 | 0.234 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.840934e-01 | 0.234 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.840934e-01 | 0.234 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.840934e-01 | 0.234 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.840934e-01 | 0.234 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.849038e-01 | 0.233 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.849038e-01 | 0.233 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.849038e-01 | 0.233 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.870085e-01 | 0.231 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.870085e-01 | 0.231 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.870085e-01 | 0.231 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.876942e-01 | 0.231 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.876942e-01 | 0.231 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.892459e-01 | 0.230 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.932407e-01 | 0.227 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.938689e-01 | 0.226 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.959980e-01 | 0.225 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.959980e-01 | 0.225 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.959980e-01 | 0.225 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.959980e-01 | 0.225 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.959980e-01 | 0.225 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.959980e-01 | 0.225 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.959980e-01 | 0.225 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.959980e-01 | 0.225 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.959980e-01 | 0.225 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.959980e-01 | 0.225 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.959980e-01 | 0.225 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.959980e-01 | 0.225 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.959980e-01 | 0.225 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.959980e-01 | 0.225 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.959980e-01 | 0.225 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.959980e-01 | 0.225 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.959980e-01 | 0.225 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.959980e-01 | 0.225 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.959980e-01 | 0.225 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.959980e-01 | 0.225 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.031007e-01 | 0.220 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.084060e-01 | 0.216 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.084060e-01 | 0.216 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.084060e-01 | 0.216 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.084060e-01 | 0.216 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.100996e-01 | 0.215 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.100996e-01 | 0.215 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.100996e-01 | 0.215 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.100996e-01 | 0.215 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.100996e-01 | 0.215 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.100996e-01 | 0.215 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.103558e-01 | 0.214 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.142952e-01 | 0.212 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.142952e-01 | 0.212 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.142952e-01 | 0.212 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.142952e-01 | 0.212 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.142952e-01 | 0.212 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.142952e-01 | 0.212 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.142952e-01 | 0.212 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.142952e-01 | 0.212 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.142952e-01 | 0.212 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.197163e-01 | 0.208 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.198721e-01 | 0.208 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.214275e-01 | 0.207 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.231467e-01 | 0.205 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.241950e-01 | 0.205 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.241950e-01 | 0.205 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.241950e-01 | 0.205 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.241950e-01 | 0.205 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.287183e-01 | 0.202 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.287183e-01 | 0.202 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.297791e-01 | 0.201 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.300045e-01 | 0.201 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.304055e-01 | 0.200 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.327336e-01 | 0.199 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.339208e-01 | 0.198 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.351708e-01 | 0.197 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.364688e-01 | 0.196 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.372390e-01 | 0.196 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.372390e-01 | 0.196 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.372390e-01 | 0.196 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.372390e-01 | 0.196 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.433528e-01 | 0.192 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.452741e-01 | 0.190 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.461261e-01 | 0.190 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.520278e-01 | 0.186 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.525974e-01 | 0.185 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.526506e-01 | 0.185 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.526506e-01 | 0.185 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.526506e-01 | 0.185 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.526506e-01 | 0.185 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.526506e-01 | 0.185 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.526506e-01 | 0.185 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.526506e-01 | 0.185 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.526506e-01 | 0.185 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.526506e-01 | 0.185 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.526506e-01 | 0.185 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.526506e-01 | 0.185 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.526506e-01 | 0.185 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.563104e-01 | 0.183 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.563104e-01 | 0.183 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 6.612315e-01 | 0.180 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.612315e-01 | 0.180 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.612315e-01 | 0.180 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.612315e-01 | 0.180 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.631177e-01 | 0.178 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.631177e-01 | 0.178 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.631177e-01 | 0.178 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.631177e-01 | 0.178 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.721774e-01 | 0.173 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.744464e-01 | 0.171 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.744464e-01 | 0.171 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.744464e-01 | 0.171 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.744464e-01 | 0.171 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.744464e-01 | 0.171 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.744464e-01 | 0.171 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.744464e-01 | 0.171 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.744464e-01 | 0.171 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.748827e-01 | 0.171 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.755281e-01 | 0.170 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.787981e-01 | 0.168 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.787981e-01 | 0.168 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.808891e-01 | 0.167 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.837200e-01 | 0.165 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.837200e-01 | 0.165 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.877089e-01 | 0.163 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.920982e-01 | 0.160 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.928686e-01 | 0.159 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.952739e-01 | 0.158 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.952739e-01 | 0.158 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.952739e-01 | 0.158 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.952739e-01 | 0.158 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.952739e-01 | 0.158 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.952739e-01 | 0.158 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.952739e-01 | 0.158 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.952739e-01 | 0.158 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.952739e-01 | 0.158 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.952739e-01 | 0.158 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.952739e-01 | 0.158 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 6.952739e-01 | 0.158 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.008861e-01 | 0.154 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.008861e-01 | 0.154 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 7.013617e-01 | 0.154 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 7.013617e-01 | 0.154 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.013617e-01 | 0.154 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.013617e-01 | 0.154 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 7.013617e-01 | 0.154 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 7.013617e-01 | 0.154 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.013617e-01 | 0.154 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.013617e-01 | 0.154 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.013617e-01 | 0.154 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.013617e-01 | 0.154 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.013617e-01 | 0.154 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 7.013617e-01 | 0.154 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 7.013617e-01 | 0.154 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 7.013617e-01 | 0.154 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 7.013617e-01 | 0.154 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.013617e-01 | 0.154 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 7.013617e-01 | 0.154 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 7.013617e-01 | 0.154 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.013617e-01 | 0.154 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 7.013617e-01 | 0.154 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.013617e-01 | 0.154 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 7.013617e-01 | 0.154 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.017360e-01 | 0.154 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.018087e-01 | 0.154 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.018087e-01 | 0.154 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.018087e-01 | 0.154 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.056716e-01 | 0.151 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.056716e-01 | 0.151 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.069122e-01 | 0.151 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.092936e-01 | 0.149 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.110013e-01 | 0.148 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.110013e-01 | 0.148 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.120508e-01 | 0.147 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.120508e-01 | 0.147 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.120508e-01 | 0.147 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.130665e-01 | 0.147 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.173770e-01 | 0.144 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.207436e-01 | 0.142 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.207436e-01 | 0.142 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.230594e-01 | 0.141 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.230594e-01 | 0.141 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.238371e-01 | 0.140 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 7.264335e-01 | 0.139 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 7.264335e-01 | 0.139 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.264335e-01 | 0.139 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.264335e-01 | 0.139 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.273802e-01 | 0.138 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.273802e-01 | 0.138 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.273802e-01 | 0.138 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.273802e-01 | 0.138 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.278881e-01 | 0.138 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.283396e-01 | 0.138 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.283396e-01 | 0.138 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.316799e-01 | 0.136 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.329965e-01 | 0.135 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.329965e-01 | 0.135 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.370754e-01 | 0.132 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.401890e-01 | 0.131 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.432442e-01 | 0.129 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.432442e-01 | 0.129 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.432442e-01 | 0.129 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.432442e-01 | 0.129 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.432442e-01 | 0.129 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.432442e-01 | 0.129 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.432442e-01 | 0.129 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.432442e-01 | 0.129 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.432442e-01 | 0.129 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.432442e-01 | 0.129 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 7.432442e-01 | 0.129 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.478975e-01 | 0.126 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.478975e-01 | 0.126 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.480084e-01 | 0.126 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.485474e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.486811e-01 | 0.126 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.511982e-01 | 0.124 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.511982e-01 | 0.124 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.511982e-01 | 0.124 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.511982e-01 | 0.124 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.511982e-01 | 0.124 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.511982e-01 | 0.124 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.537077e-01 | 0.123 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.548493e-01 | 0.122 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.548493e-01 | 0.122 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.573951e-01 | 0.121 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.586211e-01 | 0.120 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.586211e-01 | 0.120 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.586211e-01 | 0.120 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.586211e-01 | 0.120 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.689626e-01 | 0.114 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.704785e-01 | 0.113 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.708355e-01 | 0.113 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.709278e-01 | 0.113 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.731575e-01 | 0.112 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.733145e-01 | 0.112 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.733145e-01 | 0.112 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.774219e-01 | 0.109 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.778017e-01 | 0.109 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.792549e-01 | 0.108 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.792549e-01 | 0.108 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.792549e-01 | 0.108 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.792549e-01 | 0.108 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.792549e-01 | 0.108 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.792549e-01 | 0.108 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.792549e-01 | 0.108 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.792549e-01 | 0.108 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 7.792549e-01 | 0.108 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.792549e-01 | 0.108 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.792549e-01 | 0.108 | 0 | 0 |
| Biosynthesis of maresin conjugates in tissue regeneration (MCTR) | R-HSA-9026762 | 7.792549e-01 | 0.108 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.792549e-01 | 0.108 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.803971e-01 | 0.108 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.806778e-01 | 0.108 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.806778e-01 | 0.108 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.806778e-01 | 0.108 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.806778e-01 | 0.108 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.806778e-01 | 0.108 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.806778e-01 | 0.108 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.806778e-01 | 0.108 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.806778e-01 | 0.108 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.806778e-01 | 0.108 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 7.806778e-01 | 0.108 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.812818e-01 | 0.107 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.908606e-01 | 0.102 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.913766e-01 | 0.102 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.937921e-01 | 0.100 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.937921e-01 | 0.100 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.937921e-01 | 0.100 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.937921e-01 | 0.100 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.937921e-01 | 0.100 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.937921e-01 | 0.100 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.943983e-01 | 0.100 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.954131e-01 | 0.099 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.954131e-01 | 0.099 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.970917e-01 | 0.098 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.019487e-01 | 0.096 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.040858e-01 | 0.095 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.040858e-01 | 0.095 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.040858e-01 | 0.095 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.040858e-01 | 0.095 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.040858e-01 | 0.095 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.079854e-01 | 0.093 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.084020e-01 | 0.092 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.096259e-01 | 0.092 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.096259e-01 | 0.092 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 8.102168e-01 | 0.091 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 8.102168e-01 | 0.091 | 0 | 0 |
| RSK activation | R-HSA-444257 | 8.102168e-01 | 0.091 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 8.102168e-01 | 0.091 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.102168e-01 | 0.091 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 8.102168e-01 | 0.091 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 8.102168e-01 | 0.091 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.102168e-01 | 0.091 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 8.102168e-01 | 0.091 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.102168e-01 | 0.091 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 8.102168e-01 | 0.091 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 8.102168e-01 | 0.091 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.102168e-01 | 0.091 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 8.102168e-01 | 0.091 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 8.102168e-01 | 0.091 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 8.102168e-01 | 0.091 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 8.102168e-01 | 0.091 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 8.102168e-01 | 0.091 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 8.102168e-01 | 0.091 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.116349e-01 | 0.091 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.127020e-01 | 0.090 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.127020e-01 | 0.090 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.127020e-01 | 0.090 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.127020e-01 | 0.090 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.127020e-01 | 0.090 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.170662e-01 | 0.088 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.230540e-01 | 0.085 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.242760e-01 | 0.084 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.248934e-01 | 0.084 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.252441e-01 | 0.083 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.252441e-01 | 0.083 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.252441e-01 | 0.083 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.252441e-01 | 0.083 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.252441e-01 | 0.083 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.252441e-01 | 0.083 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.252441e-01 | 0.083 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.301212e-01 | 0.081 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.301212e-01 | 0.081 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.323344e-01 | 0.080 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.361846e-01 | 0.078 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.361846e-01 | 0.078 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.365749e-01 | 0.077 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.368375e-01 | 0.077 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 8.368375e-01 | 0.077 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.368375e-01 | 0.077 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.368375e-01 | 0.077 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.368375e-01 | 0.077 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 8.368375e-01 | 0.077 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 8.368375e-01 | 0.077 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.368375e-01 | 0.077 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.368375e-01 | 0.077 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.368375e-01 | 0.077 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.368375e-01 | 0.077 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 8.368375e-01 | 0.077 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.377556e-01 | 0.077 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.393588e-01 | 0.076 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.410595e-01 | 0.075 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.414820e-01 | 0.075 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.443230e-01 | 0.073 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.443230e-01 | 0.073 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.443230e-01 | 0.073 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.443230e-01 | 0.073 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.461300e-01 | 0.073 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.461300e-01 | 0.073 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.462112e-01 | 0.073 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.489560e-01 | 0.071 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.489599e-01 | 0.071 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.489599e-01 | 0.071 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.509336e-01 | 0.070 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.527575e-01 | 0.069 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.527575e-01 | 0.069 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.527575e-01 | 0.069 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.588505e-01 | 0.066 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.597255e-01 | 0.066 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.597255e-01 | 0.066 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.597255e-01 | 0.066 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.597255e-01 | 0.066 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.597255e-01 | 0.066 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.597255e-01 | 0.066 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.597255e-01 | 0.066 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.597255e-01 | 0.066 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.597255e-01 | 0.066 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.597255e-01 | 0.066 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.597255e-01 | 0.066 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.597255e-01 | 0.066 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.597255e-01 | 0.066 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.608110e-01 | 0.065 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.608110e-01 | 0.065 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.608975e-01 | 0.065 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.608975e-01 | 0.065 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.608975e-01 | 0.065 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.608975e-01 | 0.065 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.614895e-01 | 0.065 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.614895e-01 | 0.065 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.614895e-01 | 0.065 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.621159e-01 | 0.064 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.654648e-01 | 0.063 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.654648e-01 | 0.063 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.664056e-01 | 0.062 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.671890e-01 | 0.062 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.683371e-01 | 0.061 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.692165e-01 | 0.061 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.703289e-01 | 0.060 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.720333e-01 | 0.059 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 8.742469e-01 | 0.058 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.769047e-01 | 0.057 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.769047e-01 | 0.057 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.769047e-01 | 0.057 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.769047e-01 | 0.057 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.772190e-01 | 0.057 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.772190e-01 | 0.057 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.776925e-01 | 0.057 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.792270e-01 | 0.056 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.792270e-01 | 0.056 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.792270e-01 | 0.056 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.794039e-01 | 0.056 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.794039e-01 | 0.056 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.794039e-01 | 0.056 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.794039e-01 | 0.056 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.794039e-01 | 0.056 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.794039e-01 | 0.056 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.794039e-01 | 0.056 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.794039e-01 | 0.056 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.794039e-01 | 0.056 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.794039e-01 | 0.056 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.794039e-01 | 0.056 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.794039e-01 | 0.056 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.794039e-01 | 0.056 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.794039e-01 | 0.056 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.824040e-01 | 0.054 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.824040e-01 | 0.054 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.833972e-01 | 0.054 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.865200e-01 | 0.052 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.865200e-01 | 0.052 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.880724e-01 | 0.052 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.880724e-01 | 0.052 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.880724e-01 | 0.052 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.880724e-01 | 0.052 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.907220e-01 | 0.050 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.907220e-01 | 0.050 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.907220e-01 | 0.050 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.907220e-01 | 0.050 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.907220e-01 | 0.050 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.907220e-01 | 0.050 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.923411e-01 | 0.049 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.959275e-01 | 0.048 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.963227e-01 | 0.048 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.963227e-01 | 0.048 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.963227e-01 | 0.048 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.963227e-01 | 0.048 | 0 | 0 |
| FMO oxidises nucleophiles | R-HSA-217271 | 8.963227e-01 | 0.048 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.963227e-01 | 0.048 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.963227e-01 | 0.048 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.963227e-01 | 0.048 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.963227e-01 | 0.048 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.977109e-01 | 0.047 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.980774e-01 | 0.047 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.010000e-01 | 0.045 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.010000e-01 | 0.045 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.010000e-01 | 0.045 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.023922e-01 | 0.045 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.030862e-01 | 0.044 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.030862e-01 | 0.044 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.030862e-01 | 0.044 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.030862e-01 | 0.044 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.051108e-01 | 0.043 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.072855e-01 | 0.042 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.078976e-01 | 0.042 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.078976e-01 | 0.042 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.078976e-01 | 0.042 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.078976e-01 | 0.042 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.078976e-01 | 0.042 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.092999e-01 | 0.041 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.092999e-01 | 0.041 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.108688e-01 | 0.041 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.108688e-01 | 0.041 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 9.108688e-01 | 0.041 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 9.108688e-01 | 0.041 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 9.108688e-01 | 0.041 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.108688e-01 | 0.041 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 9.108688e-01 | 0.041 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 9.108688e-01 | 0.041 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 9.108688e-01 | 0.041 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 9.108688e-01 | 0.041 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 9.108688e-01 | 0.041 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 9.108688e-01 | 0.041 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.126045e-01 | 0.040 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.126045e-01 | 0.040 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.141330e-01 | 0.039 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.141330e-01 | 0.039 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.141330e-01 | 0.039 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.141330e-01 | 0.039 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.141330e-01 | 0.039 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.141330e-01 | 0.039 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.157474e-01 | 0.038 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.157474e-01 | 0.038 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.169836e-01 | 0.038 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.171556e-01 | 0.038 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.171556e-01 | 0.038 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.195785e-01 | 0.036 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.195785e-01 | 0.036 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.233747e-01 | 0.035 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.233747e-01 | 0.035 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.233747e-01 | 0.035 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.233747e-01 | 0.035 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.233747e-01 | 0.035 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.233747e-01 | 0.035 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.233747e-01 | 0.035 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.233747e-01 | 0.035 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 9.233747e-01 | 0.035 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.233747e-01 | 0.035 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.233747e-01 | 0.035 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.233747e-01 | 0.035 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.239887e-01 | 0.034 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.239887e-01 | 0.034 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.239887e-01 | 0.034 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.239887e-01 | 0.034 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.239887e-01 | 0.034 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.239887e-01 | 0.034 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.302484e-01 | 0.031 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.302484e-01 | 0.031 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.319051e-01 | 0.031 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.319051e-01 | 0.031 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.320787e-01 | 0.031 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.320787e-01 | 0.031 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.327699e-01 | 0.030 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.327699e-01 | 0.030 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.340548e-01 | 0.030 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.341266e-01 | 0.030 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.341266e-01 | 0.030 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.341266e-01 | 0.030 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 9.341266e-01 | 0.030 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.341266e-01 | 0.030 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.341266e-01 | 0.030 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 9.341266e-01 | 0.030 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.341266e-01 | 0.030 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.341266e-01 | 0.030 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.341266e-01 | 0.030 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.341266e-01 | 0.030 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.341266e-01 | 0.030 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.371382e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.400584e-01 | 0.027 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.405840e-01 | 0.027 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.405840e-01 | 0.027 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.416867e-01 | 0.026 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.428035e-01 | 0.026 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.428275e-01 | 0.026 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.433703e-01 | 0.025 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.433703e-01 | 0.025 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.433703e-01 | 0.025 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.433703e-01 | 0.025 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.433703e-01 | 0.025 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.433703e-01 | 0.025 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.433703e-01 | 0.025 | 0 | 0 |
| Events associated with phagocytolytic activity of PMN cells | R-HSA-8941413 | 9.433703e-01 | 0.025 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.433703e-01 | 0.025 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.433703e-01 | 0.025 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 9.433703e-01 | 0.025 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.433703e-01 | 0.025 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.462842e-01 | 0.024 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.462842e-01 | 0.024 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.462842e-01 | 0.024 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.462842e-01 | 0.024 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.475296e-01 | 0.023 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.475296e-01 | 0.023 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.475296e-01 | 0.023 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.475296e-01 | 0.023 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.475296e-01 | 0.023 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.476093e-01 | 0.023 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.481803e-01 | 0.023 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.513173e-01 | 0.022 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.513173e-01 | 0.022 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.513173e-01 | 0.022 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.513173e-01 | 0.022 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.513173e-01 | 0.022 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.513173e-01 | 0.022 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.513173e-01 | 0.022 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.513173e-01 | 0.022 | 0 | 0 |
| Carnitine synthesis | R-HSA-71262 | 9.513173e-01 | 0.022 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.513173e-01 | 0.022 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.513173e-01 | 0.022 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.513173e-01 | 0.022 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.515175e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.519039e-01 | 0.021 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.520287e-01 | 0.021 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.520287e-01 | 0.021 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.520975e-01 | 0.021 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.534728e-01 | 0.021 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.536964e-01 | 0.021 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.536964e-01 | 0.021 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.536964e-01 | 0.021 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.536964e-01 | 0.021 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.539230e-01 | 0.020 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.541238e-01 | 0.020 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.550954e-01 | 0.020 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.564193e-01 | 0.019 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.569706e-01 | 0.019 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.569706e-01 | 0.019 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.581496e-01 | 0.019 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.581496e-01 | 0.019 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.581496e-01 | 0.019 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.581496e-01 | 0.019 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 9.581496e-01 | 0.019 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.581496e-01 | 0.019 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.589348e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.591662e-01 | 0.018 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.591662e-01 | 0.018 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.591662e-01 | 0.018 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.619089e-01 | 0.017 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.640132e-01 | 0.016 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.640132e-01 | 0.016 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.640233e-01 | 0.016 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.640233e-01 | 0.016 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.640233e-01 | 0.016 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.656383e-01 | 0.015 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.665307e-01 | 0.015 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.683043e-01 | 0.014 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.690729e-01 | 0.014 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.690729e-01 | 0.014 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.690729e-01 | 0.014 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.690729e-01 | 0.014 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.690729e-01 | 0.014 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.690729e-01 | 0.014 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.690729e-01 | 0.014 | 0 | 0 |
| Biosynthesis of DHA-derived sulfido conjugates | R-HSA-9026395 | 9.690729e-01 | 0.014 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.690729e-01 | 0.014 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.691977e-01 | 0.014 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.693273e-01 | 0.014 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.693273e-01 | 0.014 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.699751e-01 | 0.013 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.709042e-01 | 0.013 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.726394e-01 | 0.012 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.731412e-01 | 0.012 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.734140e-01 | 0.012 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.734140e-01 | 0.012 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.734140e-01 | 0.012 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.734140e-01 | 0.012 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.734140e-01 | 0.012 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.738551e-01 | 0.012 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.742207e-01 | 0.011 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.752312e-01 | 0.011 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.754551e-01 | 0.011 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.756103e-01 | 0.011 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.756710e-01 | 0.011 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.756710e-01 | 0.011 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.756710e-01 | 0.011 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.756710e-01 | 0.011 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.771460e-01 | 0.010 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.771460e-01 | 0.010 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.771460e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.782728e-01 | 0.010 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.782728e-01 | 0.010 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.798417e-01 | 0.009 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.803543e-01 | 0.009 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.803543e-01 | 0.009 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.803543e-01 | 0.009 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.803543e-01 | 0.009 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.803543e-01 | 0.009 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.803543e-01 | 0.009 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.803543e-01 | 0.009 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.806567e-01 | 0.008 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.806567e-01 | 0.008 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.808635e-01 | 0.008 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.818989e-01 | 0.008 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.827896e-01 | 0.008 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.831123e-01 | 0.007 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.831123e-01 | 0.007 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.831123e-01 | 0.007 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.831123e-01 | 0.007 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.831123e-01 | 0.007 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.831123e-01 | 0.007 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.831123e-01 | 0.007 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.846963e-01 | 0.007 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.853725e-01 | 0.006 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.853725e-01 | 0.006 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.853725e-01 | 0.006 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.854833e-01 | 0.006 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.854833e-01 | 0.006 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.854833e-01 | 0.006 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.856880e-01 | 0.006 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.858797e-01 | 0.006 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.869426e-01 | 0.006 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.870147e-01 | 0.006 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.875216e-01 | 0.005 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.875216e-01 | 0.005 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.875216e-01 | 0.005 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.875216e-01 | 0.005 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.875321e-01 | 0.005 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.875811e-01 | 0.005 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.887410e-01 | 0.005 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.892737e-01 | 0.005 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.892737e-01 | 0.005 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.892737e-01 | 0.005 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.892737e-01 | 0.005 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.892737e-01 | 0.005 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.892737e-01 | 0.005 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.892737e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.892737e-01 | 0.005 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.892759e-01 | 0.005 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.896655e-01 | 0.005 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.901261e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.901261e-01 | 0.004 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.901261e-01 | 0.004 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.901886e-01 | 0.004 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.906297e-01 | 0.004 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.907799e-01 | 0.004 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.907799e-01 | 0.004 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.907799e-01 | 0.004 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.907799e-01 | 0.004 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.907799e-01 | 0.004 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.908374e-01 | 0.004 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.914715e-01 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.917592e-01 | 0.004 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.920747e-01 | 0.003 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.920747e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.922677e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.924173e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.929249e-01 | 0.003 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.931877e-01 | 0.003 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.931877e-01 | 0.003 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.931877e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.931877e-01 | 0.003 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.931877e-01 | 0.003 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.933588e-01 | 0.003 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.933588e-01 | 0.003 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.933588e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.937176e-01 | 0.003 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.938924e-01 | 0.003 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.938924e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.938924e-01 | 0.003 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.941445e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.941855e-01 | 0.003 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.942311e-01 | 0.003 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.942311e-01 | 0.003 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.942853e-01 | 0.002 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.946665e-01 | 0.002 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.948436e-01 | 0.002 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.949669e-01 | 0.002 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.949669e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.949669e-01 | 0.002 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.949669e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.952488e-01 | 0.002 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.955475e-01 | 0.002 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.956739e-01 | 0.002 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.956739e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.961292e-01 | 0.002 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.962185e-01 | 0.002 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.962816e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.962816e-01 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.966773e-01 | 0.001 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.968039e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.972529e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.973295e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.973295e-01 | 0.001 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.976389e-01 | 0.001 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.976389e-01 | 0.001 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.979706e-01 | 0.001 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.979706e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.980705e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.981505e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.982034e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.982558e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.982558e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.982558e-01 | 0.001 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.983302e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.984874e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.984874e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.987116e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.989622e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.990327e-01 | 0.000 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.990483e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.990957e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.991329e-01 | 0.000 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.991820e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.992361e-01 | 0.000 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.992970e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.993920e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.993958e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.994197e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.994577e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.994577e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.994577e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.994808e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.995538e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.995591e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.995666e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.996163e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.996163e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.996165e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.996510e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.996568e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.996704e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.996913e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.997168e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.997285e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997411e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997616e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997726e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.997788e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.997807e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.997908e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998075e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.998202e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.998202e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.998202e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998498e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.998529e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998548e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998569e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.998672e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.998737e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999077e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999170e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999278e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999351e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999373e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999378e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999526e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999566e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999605e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999643e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.999690e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.999709e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999749e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999755e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999773e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999785e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999785e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999797e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999797e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999809e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999815e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999815e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999841e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.999883e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999897e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999899e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999913e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999926e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999936e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999951e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999953e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999953e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999961e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999976e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999977e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999978e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999991e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999991e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999994e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999996e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999996e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999998e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999999e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1-dependent transactivation | R-HSA-3371571 | 2.153833e-14 | 13.667 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.781065e-14 | 13.010 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.106049e-13 | 12.041 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.206834e-10 | 9.918 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.323408e-10 | 9.364 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.591944e-10 | 9.018 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.366951e-09 | 8.864 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.339031e-09 | 8.476 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.234323e-09 | 8.084 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.292785e-08 | 7.482 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.749664e-08 | 7.426 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.437373e-08 | 7.353 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.260843e-07 | 6.899 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.223418e-07 | 6.912 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.008163e-07 | 6.697 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.948756e-07 | 6.710 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.513106e-07 | 6.600 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.926719e-07 | 6.534 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.392192e-07 | 6.470 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.615193e-07 | 6.442 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.451400e-07 | 6.352 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.142914e-07 | 6.383 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.393598e-07 | 6.357 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.219367e-07 | 6.282 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.880658e-07 | 6.231 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.752417e-07 | 6.240 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.977732e-07 | 6.156 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.758626e-07 | 6.170 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.636731e-07 | 6.117 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.795580e-07 | 6.056 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.442535e-07 | 6.025 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.527429e-06 | 5.816 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.674364e-06 | 5.776 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.771091e-06 | 5.752 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.910599e-06 | 5.719 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.963659e-06 | 5.707 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.037486e-06 | 5.691 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.258986e-06 | 5.646 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.318550e-06 | 5.479 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.348409e-06 | 5.475 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.885810e-06 | 5.411 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.885810e-06 | 5.411 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.077662e-06 | 5.390 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.701562e-06 | 5.328 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.921838e-06 | 5.308 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.750886e-06 | 5.171 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.092904e-06 | 5.092 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.955782e-06 | 5.099 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 9.108115e-06 | 5.041 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.993766e-06 | 5.000 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.091464e-05 | 4.962 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.135733e-05 | 4.945 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.265997e-05 | 4.898 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.414098e-05 | 4.850 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.673526e-05 | 4.776 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.684925e-05 | 4.773 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.180454e-05 | 4.661 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.394403e-05 | 4.621 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.395485e-05 | 4.469 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.395485e-05 | 4.469 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.395485e-05 | 4.469 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.395485e-05 | 4.469 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.736031e-05 | 4.428 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.738329e-05 | 4.427 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.911169e-05 | 4.408 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.160611e-05 | 4.381 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.582140e-05 | 4.339 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.964985e-05 | 4.304 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.429709e-05 | 4.265 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.895018e-05 | 4.161 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.612337e-05 | 4.017 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.293940e-04 | 3.888 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.371700e-04 | 3.863 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.407434e-04 | 3.852 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.449539e-04 | 3.839 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.478093e-04 | 3.830 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.926227e-04 | 3.715 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.421702e-04 | 3.616 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.546370e-04 | 3.594 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.638298e-04 | 3.579 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.048336e-04 | 3.516 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.210595e-04 | 3.493 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.354416e-04 | 3.474 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.797151e-04 | 3.421 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.215476e-04 | 3.375 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.011305e-04 | 3.397 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.277748e-04 | 3.369 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.361640e-04 | 3.360 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.058881e-04 | 3.296 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.922419e-04 | 3.308 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.924137e-04 | 3.308 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.138464e-04 | 3.289 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.109290e-04 | 3.292 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.058881e-04 | 3.296 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.662325e-04 | 3.331 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.924137e-04 | 3.308 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.173889e-04 | 3.286 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.613623e-04 | 3.251 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.026125e-04 | 3.220 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.178834e-04 | 3.209 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.098069e-04 | 3.149 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.613606e-04 | 3.118 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.789652e-04 | 3.108 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.168529e-04 | 3.088 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.168529e-04 | 3.088 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.251794e-04 | 3.083 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.262395e-04 | 3.083 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.478034e-04 | 3.072 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.903433e-04 | 3.050 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.596130e-04 | 3.018 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.077575e-03 | 2.968 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.021909e-03 | 2.991 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.101367e-03 | 2.958 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.202566e-03 | 2.920 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.281842e-03 | 2.892 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.284117e-03 | 2.891 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.514673e-03 | 2.820 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.456782e-03 | 2.837 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.548179e-03 | 2.810 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.699411e-03 | 2.770 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.750519e-03 | 2.757 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.755131e-03 | 2.756 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.844890e-03 | 2.734 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.914332e-03 | 2.718 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.165038e-03 | 2.665 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.027549e-03 | 2.693 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.195944e-03 | 2.658 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.224379e-03 | 2.653 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.659351e-03 | 2.575 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.745778e-03 | 2.561 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.702987e-03 | 2.568 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.754480e-03 | 2.560 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.721345e-03 | 2.565 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.904503e-03 | 2.537 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.911557e-03 | 2.536 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.911557e-03 | 2.536 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.946646e-03 | 2.531 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.307982e-03 | 2.480 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.840744e-03 | 2.416 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.430189e-03 | 2.465 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.106820e-03 | 2.508 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.106820e-03 | 2.508 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.421779e-03 | 2.466 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.720184e-03 | 2.429 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.323810e-03 | 2.478 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.833696e-03 | 2.416 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.659862e-03 | 2.437 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.323810e-03 | 2.478 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.791556e-03 | 2.421 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.138808e-03 | 2.503 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.611181e-03 | 2.442 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.575316e-03 | 2.447 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.287720e-03 | 2.483 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.532812e-03 | 2.452 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.844222e-03 | 2.415 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.844222e-03 | 2.415 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.844222e-03 | 2.415 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.881735e-03 | 2.411 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.911524e-03 | 2.408 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.968097e-03 | 2.401 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.170266e-03 | 2.380 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.295823e-03 | 2.367 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.691861e-03 | 2.329 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.786737e-03 | 2.320 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.788068e-03 | 2.320 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.788068e-03 | 2.320 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.788068e-03 | 2.320 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.788068e-03 | 2.320 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.801091e-03 | 2.319 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.914836e-03 | 2.308 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.003179e-03 | 2.301 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.175920e-03 | 2.286 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.224524e-03 | 2.282 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.294199e-03 | 2.276 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.448899e-03 | 2.264 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.477099e-03 | 2.261 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.452831e-03 | 2.263 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.231640e-03 | 2.205 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.354313e-03 | 2.197 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.383713e-03 | 2.195 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.766030e-03 | 2.170 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.818993e-03 | 2.166 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.840466e-03 | 2.165 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.840466e-03 | 2.165 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.936877e-03 | 2.159 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.004081e-03 | 2.155 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.210720e-03 | 2.142 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.315526e-03 | 2.136 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.511307e-03 | 2.124 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.783065e-03 | 2.109 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.783065e-03 | 2.109 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.850879e-03 | 2.105 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.850879e-03 | 2.105 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.853001e-03 | 2.105 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.993845e-03 | 2.097 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.993845e-03 | 2.097 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 9.440060e-03 | 2.025 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 9.022522e-03 | 2.045 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.258738e-03 | 2.033 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.329700e-03 | 2.079 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.394304e-03 | 2.076 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.022522e-03 | 2.045 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.102525e-03 | 2.041 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 9.440060e-03 | 2.025 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.526758e-03 | 2.021 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.022522e-03 | 2.045 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.392043e-03 | 2.076 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 8.187900e-03 | 2.087 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 8.187900e-03 | 2.087 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.692917e-03 | 2.014 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.875904e-03 | 2.005 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.875904e-03 | 2.005 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.925623e-03 | 2.003 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.008399e-02 | 1.996 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.008399e-02 | 1.996 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.058659e-02 | 1.975 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.058659e-02 | 1.975 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.090011e-02 | 1.963 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.131800e-02 | 1.946 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.132215e-02 | 1.946 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.152172e-02 | 1.938 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.152172e-02 | 1.938 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.152172e-02 | 1.938 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.166335e-02 | 1.933 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.193858e-02 | 1.923 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.201492e-02 | 1.920 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.209970e-02 | 1.917 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.217715e-02 | 1.914 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.224749e-02 | 1.912 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.228610e-02 | 1.911 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.228610e-02 | 1.911 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.244080e-02 | 1.905 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.264952e-02 | 1.898 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.328163e-02 | 1.877 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.334624e-02 | 1.875 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.339999e-02 | 1.873 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.396050e-02 | 1.855 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.422784e-02 | 1.847 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.426493e-02 | 1.846 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.442084e-02 | 1.841 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.447303e-02 | 1.839 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.450643e-02 | 1.838 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.656449e-02 | 1.781 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.477525e-02 | 1.830 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.477525e-02 | 1.830 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.551510e-02 | 1.809 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.614871e-02 | 1.792 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.621847e-02 | 1.790 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.480629e-02 | 1.830 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.579598e-02 | 1.801 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.551510e-02 | 1.809 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.507455e-02 | 1.822 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.761824e-02 | 1.754 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.694245e-02 | 1.771 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.707933e-02 | 1.768 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.767278e-02 | 1.753 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.767278e-02 | 1.753 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.767278e-02 | 1.753 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.767278e-02 | 1.753 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.767278e-02 | 1.753 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.774572e-02 | 1.751 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.774572e-02 | 1.751 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.785924e-02 | 1.748 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.791273e-02 | 1.747 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.791273e-02 | 1.747 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.793220e-02 | 1.746 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.795836e-02 | 1.746 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.795836e-02 | 1.746 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.841321e-02 | 1.735 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.947573e-02 | 1.711 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.954595e-02 | 1.709 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.038156e-02 | 1.691 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.061216e-02 | 1.686 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.095920e-02 | 1.679 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.111955e-02 | 1.675 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.111955e-02 | 1.675 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.111955e-02 | 1.675 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.111955e-02 | 1.675 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.111955e-02 | 1.675 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.111955e-02 | 1.675 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.111955e-02 | 1.675 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.111955e-02 | 1.675 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.111955e-02 | 1.675 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.117453e-02 | 1.674 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.138506e-02 | 1.670 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.169991e-02 | 1.664 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.230350e-02 | 1.652 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.284070e-02 | 1.641 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.284070e-02 | 1.641 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.284070e-02 | 1.641 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.324510e-02 | 1.634 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.337625e-02 | 1.631 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.361529e-02 | 1.627 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.397473e-02 | 1.620 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.397473e-02 | 1.620 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.889981e-02 | 1.539 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.638756e-02 | 1.579 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.638756e-02 | 1.579 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.912772e-02 | 1.536 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.681650e-02 | 1.572 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.436376e-02 | 1.613 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.691373e-02 | 1.570 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.670069e-02 | 1.573 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.660245e-02 | 1.575 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.854381e-02 | 1.544 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.036713e-02 | 1.518 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.603707e-02 | 1.584 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.565194e-02 | 1.591 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.504998e-02 | 1.601 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.504998e-02 | 1.601 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.983421e-02 | 1.525 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.048708e-02 | 1.516 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.073592e-02 | 1.512 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.098293e-02 | 1.509 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.138320e-02 | 1.503 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.147906e-02 | 1.502 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.147906e-02 | 1.502 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.151846e-02 | 1.501 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.165429e-02 | 1.500 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.206938e-02 | 1.494 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.262172e-02 | 1.486 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.311085e-02 | 1.480 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.367595e-02 | 1.473 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.367595e-02 | 1.473 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.381485e-02 | 1.471 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.381485e-02 | 1.471 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.381485e-02 | 1.471 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.423290e-02 | 1.466 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.423290e-02 | 1.466 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.547812e-02 | 1.450 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.711157e-02 | 1.430 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.711157e-02 | 1.430 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.711157e-02 | 1.430 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.717100e-02 | 1.430 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 3.717100e-02 | 1.430 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.717100e-02 | 1.430 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.406148e-02 | 1.356 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.406148e-02 | 1.356 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.931349e-02 | 1.405 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.931349e-02 | 1.405 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.931349e-02 | 1.405 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.959126e-02 | 1.402 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.042376e-02 | 1.297 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.042376e-02 | 1.297 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.423346e-02 | 1.354 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.117525e-02 | 1.385 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.553312e-02 | 1.342 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.048954e-02 | 1.393 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.821285e-02 | 1.317 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.821285e-02 | 1.317 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.173172e-02 | 1.380 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.897795e-02 | 1.409 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.878616e-02 | 1.411 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.782568e-02 | 1.320 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.348138e-02 | 1.362 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.295277e-02 | 1.367 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.483400e-02 | 1.348 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.739968e-02 | 1.324 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.931349e-02 | 1.405 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.406148e-02 | 1.356 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.042376e-02 | 1.297 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.782568e-02 | 1.320 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.490447e-02 | 1.348 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.913373e-02 | 1.407 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.406148e-02 | 1.356 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.970082e-02 | 1.304 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.213799e-02 | 1.375 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.139804e-02 | 1.383 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.139804e-02 | 1.383 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.139804e-02 | 1.383 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.970082e-02 | 1.304 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.295277e-02 | 1.367 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.821285e-02 | 1.317 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.959126e-02 | 1.402 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.959126e-02 | 1.402 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.807035e-02 | 1.419 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.348138e-02 | 1.362 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.912010e-02 | 1.309 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.042376e-02 | 1.297 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.931349e-02 | 1.405 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.217047e-02 | 1.283 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.226891e-02 | 1.282 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.269682e-02 | 1.278 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.368727e-02 | 1.270 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.399247e-02 | 1.268 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.412266e-02 | 1.267 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.481467e-02 | 1.261 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.515907e-02 | 1.258 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.558759e-02 | 1.255 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.595128e-02 | 1.252 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.605632e-02 | 1.251 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.605632e-02 | 1.251 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.607082e-02 | 1.251 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.683077e-02 | 1.245 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.745015e-02 | 1.241 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.745015e-02 | 1.241 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.800722e-02 | 1.237 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.840964e-02 | 1.234 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.840964e-02 | 1.234 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.840964e-02 | 1.234 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.840964e-02 | 1.234 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.840964e-02 | 1.234 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.840964e-02 | 1.234 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.840964e-02 | 1.234 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.840964e-02 | 1.234 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.840964e-02 | 1.234 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.840964e-02 | 1.234 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.840964e-02 | 1.234 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.840964e-02 | 1.234 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.852460e-02 | 1.233 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.863585e-02 | 1.232 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.887845e-02 | 1.230 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.009759e-02 | 1.221 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.081446e-02 | 1.216 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.134444e-02 | 1.212 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.134444e-02 | 1.212 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.136479e-02 | 1.212 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.141275e-02 | 1.212 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.141275e-02 | 1.212 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.141275e-02 | 1.212 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.141275e-02 | 1.212 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.159555e-02 | 1.210 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.186129e-02 | 1.209 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.190018e-02 | 1.208 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.190018e-02 | 1.208 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.190018e-02 | 1.208 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.408757e-02 | 1.193 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.458475e-02 | 1.190 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.458475e-02 | 1.190 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.463084e-02 | 1.190 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.463084e-02 | 1.190 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.250359e-02 | 1.034 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.250359e-02 | 1.034 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.250359e-02 | 1.034 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.250359e-02 | 1.034 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 8.575935e-02 | 1.067 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 8.575935e-02 | 1.067 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.237502e-02 | 1.140 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.556234e-02 | 1.183 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.708844e-02 | 1.060 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.511118e-02 | 1.124 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.233078e-02 | 1.141 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.233078e-02 | 1.141 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.233078e-02 | 1.141 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.233078e-02 | 1.141 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.864320e-02 | 1.163 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.864320e-02 | 1.163 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.928726e-02 | 1.049 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.928726e-02 | 1.049 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.928726e-02 | 1.049 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.195385e-02 | 1.143 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.195385e-02 | 1.143 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.464924e-02 | 1.072 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.476118e-02 | 1.072 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.053014e-02 | 1.043 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.843974e-02 | 1.165 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.794550e-02 | 1.108 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 9.310143e-02 | 1.031 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.477716e-02 | 1.023 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 9.310143e-02 | 1.031 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.928726e-02 | 1.049 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.143195e-02 | 1.089 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.928726e-02 | 1.049 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.141605e-02 | 1.146 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.462759e-02 | 1.072 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.603589e-02 | 1.180 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.298350e-02 | 1.032 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 9.310143e-02 | 1.031 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.249610e-02 | 1.084 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.576127e-02 | 1.067 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.477716e-02 | 1.023 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.144103e-02 | 1.089 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.758958e-02 | 1.110 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.462402e-02 | 1.127 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.342945e-02 | 1.079 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.342945e-02 | 1.079 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.596304e-02 | 1.018 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.142014e-02 | 1.039 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.721636e-02 | 1.059 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.462759e-02 | 1.072 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.985057e-02 | 1.098 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 8.575935e-02 | 1.067 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.576127e-02 | 1.067 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.233078e-02 | 1.141 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.342945e-02 | 1.079 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.147248e-02 | 1.039 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.758958e-02 | 1.110 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.928726e-02 | 1.049 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.093631e-02 | 1.149 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.928726e-02 | 1.049 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.286449e-02 | 1.032 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.928726e-02 | 1.049 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.778390e-02 | 1.010 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.539997e-02 | 1.069 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.492151e-02 | 1.125 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.556234e-02 | 1.183 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.495923e-02 | 1.022 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.631784e-02 | 1.064 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.032282e-02 | 1.095 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.233078e-02 | 1.141 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.233078e-02 | 1.141 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.342945e-02 | 1.079 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.147248e-02 | 1.039 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.411833e-02 | 1.075 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.032282e-02 | 1.095 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.723061e-02 | 1.012 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 9.310143e-02 | 1.031 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.864320e-02 | 1.163 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.416492e-02 | 1.130 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.703062e-02 | 1.060 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.176364e-02 | 1.144 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 9.853645e-02 | 1.006 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.853645e-02 | 1.006 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.853645e-02 | 1.006 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.864859e-02 | 1.006 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.886840e-02 | 1.005 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.907361e-02 | 1.004 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 9.988224e-02 | 1.001 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.988224e-02 | 1.001 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.994553e-02 | 1.000 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.002564e-01 | 0.999 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.016840e-01 | 0.993 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.024028e-01 | 0.990 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.024028e-01 | 0.990 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.037140e-01 | 0.984 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.037140e-01 | 0.984 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.043758e-01 | 0.981 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.055475e-01 | 0.977 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.055475e-01 | 0.977 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.055475e-01 | 0.977 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.055475e-01 | 0.977 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.078081e-01 | 0.967 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.082903e-01 | 0.965 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.082903e-01 | 0.965 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.082903e-01 | 0.965 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.082903e-01 | 0.965 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.084449e-01 | 0.965 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.088439e-01 | 0.963 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.118395e-01 | 0.951 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.118395e-01 | 0.951 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.118395e-01 | 0.951 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.118395e-01 | 0.951 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.128944e-01 | 0.947 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.128944e-01 | 0.947 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.128944e-01 | 0.947 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.128944e-01 | 0.947 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.128944e-01 | 0.947 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.133849e-01 | 0.945 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.143822e-01 | 0.942 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.153011e-01 | 0.938 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.154629e-01 | 0.938 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 1.154629e-01 | 0.938 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.157991e-01 | 0.936 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.157991e-01 | 0.936 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.158961e-01 | 0.936 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.159772e-01 | 0.936 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.161075e-01 | 0.935 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.161075e-01 | 0.935 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.161075e-01 | 0.935 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.161075e-01 | 0.935 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.169227e-01 | 0.932 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.181611e-01 | 0.928 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.185389e-01 | 0.926 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.185389e-01 | 0.926 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.185389e-01 | 0.926 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.185389e-01 | 0.926 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.190527e-01 | 0.924 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.199568e-01 | 0.921 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.199568e-01 | 0.921 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.224431e-01 | 0.912 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.227362e-01 | 0.911 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.227454e-01 | 0.911 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.253535e-01 | 0.902 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.253535e-01 | 0.902 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.253535e-01 | 0.902 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.253535e-01 | 0.902 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.254734e-01 | 0.901 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.255549e-01 | 0.901 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.268927e-01 | 0.897 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.268927e-01 | 0.897 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.288830e-01 | 0.890 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.288830e-01 | 0.890 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.288830e-01 | 0.890 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.292696e-01 | 0.889 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.323194e-01 | 0.878 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.323194e-01 | 0.878 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.323194e-01 | 0.878 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.323194e-01 | 0.878 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.341189e-01 | 0.873 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.341189e-01 | 0.873 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.347145e-01 | 0.871 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.764552e-01 | 0.753 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.764552e-01 | 0.753 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.764552e-01 | 0.753 | 0 | 0 |
| Blockage of phagosome acidification | R-HSA-9636467 | 1.764552e-01 | 0.753 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.764552e-01 | 0.753 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.764552e-01 | 0.753 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.764552e-01 | 0.753 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.764552e-01 | 0.753 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.764552e-01 | 0.753 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.526451e-01 | 0.597 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.526451e-01 | 0.597 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.526451e-01 | 0.597 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.526451e-01 | 0.597 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.526451e-01 | 0.597 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.526451e-01 | 0.597 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 2.526451e-01 | 0.597 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 2.526451e-01 | 0.597 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.526451e-01 | 0.597 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.486661e-01 | 0.828 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.486661e-01 | 0.828 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.827671e-01 | 0.738 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.827671e-01 | 0.738 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.178471e-01 | 0.662 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.178471e-01 | 0.662 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.565881e-01 | 0.805 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.565881e-01 | 0.805 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.565881e-01 | 0.805 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.565881e-01 | 0.805 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.565881e-01 | 0.805 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.801145e-01 | 0.744 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.534335e-01 | 0.596 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.534335e-01 | 0.596 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.534335e-01 | 0.596 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.534335e-01 | 0.596 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.534335e-01 | 0.596 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.534335e-01 | 0.596 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.497405e-01 | 0.825 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.045139e-01 | 0.689 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.045139e-01 | 0.689 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.045139e-01 | 0.689 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.045139e-01 | 0.689 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.045139e-01 | 0.689 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.045139e-01 | 0.689 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.395780e-01 | 0.855 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.296085e-01 | 0.639 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.869547e-01 | 0.728 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.869547e-01 | 0.728 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.414059e-01 | 0.850 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.065752e-01 | 0.685 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.267542e-01 | 0.644 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.267542e-01 | 0.644 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.267542e-01 | 0.644 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.267542e-01 | 0.644 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.197882e-01 | 0.658 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.197882e-01 | 0.658 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.766918e-01 | 0.753 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.594310e-01 | 0.797 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.442988e-01 | 0.841 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.895754e-01 | 0.722 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.895754e-01 | 0.722 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.706886e-01 | 0.768 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.542173e-01 | 0.812 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.750156e-01 | 0.757 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.318401e-01 | 0.635 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.318401e-01 | 0.635 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.449146e-01 | 0.611 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.449146e-01 | 0.611 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.717481e-01 | 0.566 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.300752e-01 | 0.638 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.241310e-01 | 0.649 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.204248e-01 | 0.657 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.521286e-01 | 0.598 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.045139e-01 | 0.689 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.380177e-01 | 0.860 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.402486e-01 | 0.853 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.896639e-01 | 0.722 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.589973e-01 | 0.587 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.543110e-01 | 0.595 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.801145e-01 | 0.744 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.065752e-01 | 0.685 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.449146e-01 | 0.611 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.486661e-01 | 0.828 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.026979e-01 | 0.693 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.485360e-01 | 0.828 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.114821e-01 | 0.675 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.697309e-01 | 0.569 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.551749e-01 | 0.593 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.395780e-01 | 0.855 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.399791e-01 | 0.854 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.383385e-01 | 0.623 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.197882e-01 | 0.658 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.691060e-01 | 0.772 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.641984e-01 | 0.785 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.433994e-01 | 0.843 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.985218e-01 | 0.702 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.711338e-01 | 0.767 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.764552e-01 | 0.753 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 2.178471e-01 | 0.662 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.045139e-01 | 0.689 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.820819e-01 | 0.740 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.485360e-01 | 0.828 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.028259e-01 | 0.693 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.359714e-01 | 0.867 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.543597e-01 | 0.811 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.827671e-01 | 0.738 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.534335e-01 | 0.596 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.360389e-01 | 0.866 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.397270e-01 | 0.855 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.714835e-01 | 0.566 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.178471e-01 | 0.662 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.895754e-01 | 0.722 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.695982e-01 | 0.569 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.263578e-01 | 0.645 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.497405e-01 | 0.825 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.942290e-01 | 0.712 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.942290e-01 | 0.712 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.267663e-01 | 0.644 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.376313e-01 | 0.624 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.114821e-01 | 0.675 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.764552e-01 | 0.753 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.526451e-01 | 0.597 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.526451e-01 | 0.597 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.486661e-01 | 0.828 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.827671e-01 | 0.738 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.801145e-01 | 0.744 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.801145e-01 | 0.744 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.801145e-01 | 0.744 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.534335e-01 | 0.596 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.045139e-01 | 0.689 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.679807e-01 | 0.775 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.544713e-01 | 0.811 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.404679e-01 | 0.852 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.404679e-01 | 0.852 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.114821e-01 | 0.675 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.028259e-01 | 0.693 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.551749e-01 | 0.593 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.589973e-01 | 0.587 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.611046e-01 | 0.583 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.670112e-01 | 0.573 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.691060e-01 | 0.772 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.557323e-01 | 0.592 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.869547e-01 | 0.728 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.793748e-01 | 0.746 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.567197e-01 | 0.805 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.458285e-01 | 0.836 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.474039e-01 | 0.607 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.641984e-01 | 0.785 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.592903e-01 | 0.586 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.534335e-01 | 0.596 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.594310e-01 | 0.797 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.028259e-01 | 0.693 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.028259e-01 | 0.693 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.942290e-01 | 0.712 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.267542e-01 | 0.644 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.628156e-01 | 0.788 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.301326e-01 | 0.638 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.338355e-01 | 0.631 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.372984e-01 | 0.625 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.551749e-01 | 0.593 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.109807e-01 | 0.676 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.895754e-01 | 0.722 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.543185e-01 | 0.812 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.801145e-01 | 0.744 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.197882e-01 | 0.658 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.766918e-01 | 0.753 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.895754e-01 | 0.722 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.808158e-01 | 0.743 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.130472e-01 | 0.672 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.795666e-01 | 0.746 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.087349e-01 | 0.680 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.433994e-01 | 0.843 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.313582e-01 | 0.636 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.303296e-01 | 0.638 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.435143e-01 | 0.843 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.178471e-01 | 0.662 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.267663e-01 | 0.644 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.445312e-01 | 0.612 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.441899e-01 | 0.612 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.062357e-01 | 0.686 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.609250e-01 | 0.793 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.589973e-01 | 0.587 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.892255e-01 | 0.723 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.520562e-01 | 0.818 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.609743e-01 | 0.793 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 2.178471e-01 | 0.662 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.801145e-01 | 0.744 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.534335e-01 | 0.596 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.895754e-01 | 0.722 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.026979e-01 | 0.693 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.617418e-01 | 0.582 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.197882e-01 | 0.658 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.318401e-01 | 0.635 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.423921e-01 | 0.615 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.178471e-01 | 0.662 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.497405e-01 | 0.825 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.635200e-01 | 0.579 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.717481e-01 | 0.566 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.869547e-01 | 0.728 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.474039e-01 | 0.607 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.589973e-01 | 0.587 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.589973e-01 | 0.587 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.026979e-01 | 0.693 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.114821e-01 | 0.675 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 2.114821e-01 | 0.675 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.318401e-01 | 0.635 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.474039e-01 | 0.607 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.114821e-01 | 0.675 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.395780e-01 | 0.855 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.184037e-01 | 0.661 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.714835e-01 | 0.566 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.733640e-01 | 0.563 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.733640e-01 | 0.563 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.737005e-01 | 0.563 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.737005e-01 | 0.563 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.745221e-01 | 0.561 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.745221e-01 | 0.561 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.806695e-01 | 0.552 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.807152e-01 | 0.552 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.812144e-01 | 0.551 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.812144e-01 | 0.551 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.812144e-01 | 0.551 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.812144e-01 | 0.551 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 2.812144e-01 | 0.551 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.827935e-01 | 0.549 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.854649e-01 | 0.544 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.854649e-01 | 0.544 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.862431e-01 | 0.543 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.891327e-01 | 0.539 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.891327e-01 | 0.539 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.891327e-01 | 0.539 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.891327e-01 | 0.539 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.891327e-01 | 0.539 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.891327e-01 | 0.539 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 2.891327e-01 | 0.539 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 2.891327e-01 | 0.539 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.891327e-01 | 0.539 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.891327e-01 | 0.539 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.891327e-01 | 0.539 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.897716e-01 | 0.538 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.909521e-01 | 0.536 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.915588e-01 | 0.535 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.918123e-01 | 0.535 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.918123e-01 | 0.535 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.968513e-01 | 0.527 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.993532e-01 | 0.524 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.037086e-01 | 0.518 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 3.037086e-01 | 0.518 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.074173e-01 | 0.512 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.074173e-01 | 0.512 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.074173e-01 | 0.512 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.075760e-01 | 0.512 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.075760e-01 | 0.512 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.075760e-01 | 0.512 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.104673e-01 | 0.508 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.113236e-01 | 0.507 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.113236e-01 | 0.507 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.113236e-01 | 0.507 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.206255e-01 | 0.494 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.217904e-01 | 0.492 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.217904e-01 | 0.492 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.217904e-01 | 0.492 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.217904e-01 | 0.492 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.217904e-01 | 0.492 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.217904e-01 | 0.492 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.217904e-01 | 0.492 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.246196e-01 | 0.489 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.246196e-01 | 0.489 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.246196e-01 | 0.489 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.246196e-01 | 0.489 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.246196e-01 | 0.489 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.246196e-01 | 0.489 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 3.246196e-01 | 0.489 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.246196e-01 | 0.489 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.246196e-01 | 0.489 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.246196e-01 | 0.489 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.292777e-01 | 0.482 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.292777e-01 | 0.482 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.292777e-01 | 0.482 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.303726e-01 | 0.481 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.320674e-01 | 0.479 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.322001e-01 | 0.479 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.330157e-01 | 0.478 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.337000e-01 | 0.477 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.412595e-01 | 0.467 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.432602e-01 | 0.464 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.491468e-01 | 0.457 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.498111e-01 | 0.456 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.522600e-01 | 0.453 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.547734e-01 | 0.450 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.561904e-01 | 0.448 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.582476e-01 | 0.446 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.582476e-01 | 0.446 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.582476e-01 | 0.446 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.582476e-01 | 0.446 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.596281e-01 | 0.444 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.596281e-01 | 0.444 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.596281e-01 | 0.444 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.596281e-01 | 0.444 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.596281e-01 | 0.444 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.599374e-01 | 0.444 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.599374e-01 | 0.444 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.599374e-01 | 0.444 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.599374e-01 | 0.444 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.599374e-01 | 0.444 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.610979e-01 | 0.442 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.610979e-01 | 0.442 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.610979e-01 | 0.442 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.657696e-01 | 0.437 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.671664e-01 | 0.435 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.671664e-01 | 0.435 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.671664e-01 | 0.435 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.671664e-01 | 0.435 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.705409e-01 | 0.431 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.706136e-01 | 0.431 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.706136e-01 | 0.431 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.733684e-01 | 0.428 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.752870e-01 | 0.426 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.752870e-01 | 0.426 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.765266e-01 | 0.424 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 3.845421e-01 | 0.415 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.845421e-01 | 0.415 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 3.845421e-01 | 0.415 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.845421e-01 | 0.415 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.845421e-01 | 0.415 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 3.845421e-01 | 0.415 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.845421e-01 | 0.415 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.845421e-01 | 0.415 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.850803e-01 | 0.414 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.850803e-01 | 0.414 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.858763e-01 | 0.414 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.858763e-01 | 0.414 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.858763e-01 | 0.414 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.860161e-01 | 0.413 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.860161e-01 | 0.413 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.861502e-01 | 0.413 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.877618e-01 | 0.411 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.939431e-01 | 0.405 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.939431e-01 | 0.405 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.982094e-01 | 0.400 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.982094e-01 | 0.400 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.982094e-01 | 0.400 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.017342e-01 | 0.396 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.017342e-01 | 0.396 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.093872e-01 | 0.388 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.093872e-01 | 0.388 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.118346e-01 | 0.385 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.118346e-01 | 0.385 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.118346e-01 | 0.385 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.140635e-01 | 0.383 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.239758e-01 | 0.373 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.263847e-01 | 0.370 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.273934e-01 | 0.369 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.273934e-01 | 0.369 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.277766e-01 | 0.369 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.289578e-01 | 0.368 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.304104e-01 | 0.366 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.373028e-01 | 0.359 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.411237e-01 | 0.355 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.414910e-01 | 0.355 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.414910e-01 | 0.355 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.414910e-01 | 0.355 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.414910e-01 | 0.355 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.414910e-01 | 0.355 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.414910e-01 | 0.355 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.414910e-01 | 0.355 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.414910e-01 | 0.355 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.414910e-01 | 0.355 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.414910e-01 | 0.355 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.414910e-01 | 0.355 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.427362e-01 | 0.354 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.427362e-01 | 0.354 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.517643e-01 | 0.345 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 4.559531e-01 | 0.341 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.598453e-01 | 0.337 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.598453e-01 | 0.337 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.598453e-01 | 0.337 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.598453e-01 | 0.337 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.598453e-01 | 0.337 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.601270e-01 | 0.337 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.623416e-01 | 0.335 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.652581e-01 | 0.332 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.768170e-01 | 0.322 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.773318e-01 | 0.321 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.797670e-01 | 0.319 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.868826e-01 | 0.313 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.868826e-01 | 0.313 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.893519e-01 | 0.310 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.911972e-01 | 0.309 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.911972e-01 | 0.309 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.911972e-01 | 0.309 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.911972e-01 | 0.309 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 4.931734e-01 | 0.307 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.931734e-01 | 0.307 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.931734e-01 | 0.307 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.931734e-01 | 0.307 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 4.931734e-01 | 0.307 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.931734e-01 | 0.307 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.931734e-01 | 0.307 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.931734e-01 | 0.307 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.931734e-01 | 0.307 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.931734e-01 | 0.307 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.931734e-01 | 0.307 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.931734e-01 | 0.307 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.933524e-01 | 0.307 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.967988e-01 | 0.304 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.978422e-01 | 0.303 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.979709e-01 | 0.303 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.045205e-01 | 0.297 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.045205e-01 | 0.297 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.108669e-01 | 0.292 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.108669e-01 | 0.292 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 5.108669e-01 | 0.292 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.140589e-01 | 0.289 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.154359e-01 | 0.288 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.159271e-01 | 0.287 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.194898e-01 | 0.284 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.213749e-01 | 0.283 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.213749e-01 | 0.283 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 5.213749e-01 | 0.283 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 5.213749e-01 | 0.283 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 5.213749e-01 | 0.283 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.213749e-01 | 0.283 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.213749e-01 | 0.283 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.224255e-01 | 0.282 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.237280e-01 | 0.281 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.237280e-01 | 0.281 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.258671e-01 | 0.279 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.342452e-01 | 0.272 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.342452e-01 | 0.272 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 5.342452e-01 | 0.272 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.400761e-01 | 0.268 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.400761e-01 | 0.268 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.400761e-01 | 0.268 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.400761e-01 | 0.268 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.400761e-01 | 0.268 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.400761e-01 | 0.268 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.400761e-01 | 0.268 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.400761e-01 | 0.268 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.400761e-01 | 0.268 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.400761e-01 | 0.268 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.400761e-01 | 0.268 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.400761e-01 | 0.268 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.400761e-01 | 0.268 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.400761e-01 | 0.268 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.408067e-01 | 0.267 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.434659e-01 | 0.265 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.434659e-01 | 0.265 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.434659e-01 | 0.265 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.434659e-01 | 0.265 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.489064e-01 | 0.261 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.489064e-01 | 0.261 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.503273e-01 | 0.259 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.503273e-01 | 0.259 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.503273e-01 | 0.259 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.503273e-01 | 0.259 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.503273e-01 | 0.259 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.503273e-01 | 0.259 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.503273e-01 | 0.259 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.509917e-01 | 0.259 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.552345e-01 | 0.256 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.569764e-01 | 0.254 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.569764e-01 | 0.254 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.575033e-01 | 0.254 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.575033e-01 | 0.254 | 0 | 0 |
| Translation | R-HSA-72766 | 5.624886e-01 | 0.250 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.633232e-01 | 0.249 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.680538e-01 | 0.246 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 5.680538e-01 | 0.246 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.680538e-01 | 0.246 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.680538e-01 | 0.246 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.680538e-01 | 0.246 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.712022e-01 | 0.243 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.712022e-01 | 0.243 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.729201e-01 | 0.242 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.734511e-01 | 0.242 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.780226e-01 | 0.238 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.780226e-01 | 0.238 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.780226e-01 | 0.238 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.780226e-01 | 0.238 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.780226e-01 | 0.238 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.780226e-01 | 0.238 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.780226e-01 | 0.238 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.780226e-01 | 0.238 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.780226e-01 | 0.238 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.790276e-01 | 0.237 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.790276e-01 | 0.237 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.790276e-01 | 0.237 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.818483e-01 | 0.235 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.826408e-01 | 0.235 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.826408e-01 | 0.235 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.826408e-01 | 0.235 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.826408e-01 | 0.235 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.826408e-01 | 0.235 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.826408e-01 | 0.235 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.826408e-01 | 0.235 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.826408e-01 | 0.235 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.826408e-01 | 0.235 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.826408e-01 | 0.235 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.826408e-01 | 0.235 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.826408e-01 | 0.235 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.826408e-01 | 0.235 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.826408e-01 | 0.235 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.826408e-01 | 0.235 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.881187e-01 | 0.231 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.957108e-01 | 0.225 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.000002e-01 | 0.222 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.000473e-01 | 0.222 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.003730e-01 | 0.222 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 6.003730e-01 | 0.222 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.011407e-01 | 0.221 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.030063e-01 | 0.220 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.044457e-01 | 0.219 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.044457e-01 | 0.219 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 6.044457e-01 | 0.219 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.044457e-01 | 0.219 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.102380e-01 | 0.215 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.150938e-01 | 0.211 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.180590e-01 | 0.209 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.209934e-01 | 0.207 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.209934e-01 | 0.207 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.212686e-01 | 0.207 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.212686e-01 | 0.207 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.212686e-01 | 0.207 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.212686e-01 | 0.207 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.212686e-01 | 0.207 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.212686e-01 | 0.207 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.212686e-01 | 0.207 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.212686e-01 | 0.207 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.212686e-01 | 0.207 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.212686e-01 | 0.207 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.212686e-01 | 0.207 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.212686e-01 | 0.207 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.212686e-01 | 0.207 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.221091e-01 | 0.206 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.232190e-01 | 0.205 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.295946e-01 | 0.201 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.295946e-01 | 0.201 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.295946e-01 | 0.201 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.318794e-01 | 0.199 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.383855e-01 | 0.195 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.408757e-01 | 0.193 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.408757e-01 | 0.193 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.425306e-01 | 0.192 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.521021e-01 | 0.186 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.521021e-01 | 0.186 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.534790e-01 | 0.185 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.534790e-01 | 0.185 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.534790e-01 | 0.185 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.534790e-01 | 0.185 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.534790e-01 | 0.185 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.534790e-01 | 0.185 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.534790e-01 | 0.185 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.534790e-01 | 0.185 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.534790e-01 | 0.185 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.563234e-01 | 0.183 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.563234e-01 | 0.183 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.563234e-01 | 0.183 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.563234e-01 | 0.183 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.563234e-01 | 0.183 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.563234e-01 | 0.183 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.563234e-01 | 0.183 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.563234e-01 | 0.183 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.563234e-01 | 0.183 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.563234e-01 | 0.183 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.563234e-01 | 0.183 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.565471e-01 | 0.183 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.567721e-01 | 0.183 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.573299e-01 | 0.182 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.593920e-01 | 0.181 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.594849e-01 | 0.181 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 6.600119e-01 | 0.180 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.619912e-01 | 0.179 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.684243e-01 | 0.175 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.684243e-01 | 0.175 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.700844e-01 | 0.174 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.727342e-01 | 0.172 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.761175e-01 | 0.170 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.761175e-01 | 0.170 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.761175e-01 | 0.170 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.761175e-01 | 0.170 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.761175e-01 | 0.170 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.783991e-01 | 0.169 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.783991e-01 | 0.169 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.783991e-01 | 0.169 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.842126e-01 | 0.165 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.842126e-01 | 0.165 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.870023e-01 | 0.163 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.881354e-01 | 0.162 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.881354e-01 | 0.162 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.881354e-01 | 0.162 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.881354e-01 | 0.162 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.881354e-01 | 0.162 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.881354e-01 | 0.162 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.881354e-01 | 0.162 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.881354e-01 | 0.162 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.881354e-01 | 0.162 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.881354e-01 | 0.162 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.881354e-01 | 0.162 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.881354e-01 | 0.162 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.881354e-01 | 0.162 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.881354e-01 | 0.162 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.960383e-01 | 0.157 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.975359e-01 | 0.156 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.975359e-01 | 0.156 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.975359e-01 | 0.156 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.975359e-01 | 0.156 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.983930e-01 | 0.156 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.994640e-01 | 0.155 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.075007e-01 | 0.150 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.129346e-01 | 0.147 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.129346e-01 | 0.147 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.129346e-01 | 0.147 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.129346e-01 | 0.147 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.141780e-01 | 0.146 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.169163e-01 | 0.145 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.170045e-01 | 0.144 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.170045e-01 | 0.144 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.170045e-01 | 0.144 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.170045e-01 | 0.144 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.170045e-01 | 0.144 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.170045e-01 | 0.144 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.170045e-01 | 0.144 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.170045e-01 | 0.144 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.170045e-01 | 0.144 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.177662e-01 | 0.144 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.177662e-01 | 0.144 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.177662e-01 | 0.144 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.177662e-01 | 0.144 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.177662e-01 | 0.144 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.186550e-01 | 0.143 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.264004e-01 | 0.139 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.264004e-01 | 0.139 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.305685e-01 | 0.136 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.328862e-01 | 0.135 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.368448e-01 | 0.133 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.420013e-01 | 0.130 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.432027e-01 | 0.129 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.432027e-01 | 0.129 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.432027e-01 | 0.129 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.432027e-01 | 0.129 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.432027e-01 | 0.129 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.432027e-01 | 0.129 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.432027e-01 | 0.129 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.432027e-01 | 0.129 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.432027e-01 | 0.129 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.432027e-01 | 0.129 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.432027e-01 | 0.129 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.445338e-01 | 0.128 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 7.445338e-01 | 0.128 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.548114e-01 | 0.122 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.548114e-01 | 0.122 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.548114e-01 | 0.122 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.548114e-01 | 0.122 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.548114e-01 | 0.122 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.548114e-01 | 0.122 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.548114e-01 | 0.122 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.551190e-01 | 0.122 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.563422e-01 | 0.121 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.572814e-01 | 0.121 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.590385e-01 | 0.120 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.592612e-01 | 0.120 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 7.592612e-01 | 0.120 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 7.669771e-01 | 0.115 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.669771e-01 | 0.115 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.669771e-01 | 0.115 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 7.669771e-01 | 0.115 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.669771e-01 | 0.115 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.669771e-01 | 0.115 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.669771e-01 | 0.115 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.669771e-01 | 0.115 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.669771e-01 | 0.115 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.669771e-01 | 0.115 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.669771e-01 | 0.115 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.669771e-01 | 0.115 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.715271e-01 | 0.113 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.717084e-01 | 0.113 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.717084e-01 | 0.113 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.717084e-01 | 0.113 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.717084e-01 | 0.113 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 7.717084e-01 | 0.113 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.732936e-01 | 0.112 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.772682e-01 | 0.109 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.783246e-01 | 0.109 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.797997e-01 | 0.108 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.797997e-01 | 0.108 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.866483e-01 | 0.104 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.875799e-01 | 0.104 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.875799e-01 | 0.104 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.875799e-01 | 0.104 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.875799e-01 | 0.104 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.875799e-01 | 0.104 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.875799e-01 | 0.104 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.879159e-01 | 0.104 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.885517e-01 | 0.103 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.885517e-01 | 0.103 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 7.885517e-01 | 0.103 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.885517e-01 | 0.103 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.885517e-01 | 0.103 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 7.885517e-01 | 0.103 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.885517e-01 | 0.103 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.885517e-01 | 0.103 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.885517e-01 | 0.103 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.885517e-01 | 0.103 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.885517e-01 | 0.103 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.885517e-01 | 0.103 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.885517e-01 | 0.103 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.885517e-01 | 0.103 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.885517e-01 | 0.103 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.885517e-01 | 0.103 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.913796e-01 | 0.102 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.964957e-01 | 0.099 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.981632e-01 | 0.098 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.993439e-01 | 0.097 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.024707e-01 | 0.096 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.024707e-01 | 0.096 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.024707e-01 | 0.096 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.024707e-01 | 0.096 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.024707e-01 | 0.096 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.024707e-01 | 0.096 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.024707e-01 | 0.096 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.080165e-01 | 0.093 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.081299e-01 | 0.093 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.081299e-01 | 0.093 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.081299e-01 | 0.093 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.081299e-01 | 0.093 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.081299e-01 | 0.093 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.081299e-01 | 0.093 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.081299e-01 | 0.093 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.081299e-01 | 0.093 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.081299e-01 | 0.093 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.081299e-01 | 0.093 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.081299e-01 | 0.093 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.081299e-01 | 0.093 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.081299e-01 | 0.093 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.134157e-01 | 0.090 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.143631e-01 | 0.089 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.164264e-01 | 0.088 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.164264e-01 | 0.088 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.164264e-01 | 0.088 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.164264e-01 | 0.088 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.228374e-01 | 0.085 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.228374e-01 | 0.085 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.258965e-01 | 0.083 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.258965e-01 | 0.083 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.258965e-01 | 0.083 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.258965e-01 | 0.083 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.258965e-01 | 0.083 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.258965e-01 | 0.083 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.258965e-01 | 0.083 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.258965e-01 | 0.083 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.258965e-01 | 0.083 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.258965e-01 | 0.083 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.258965e-01 | 0.083 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.258965e-01 | 0.083 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.258965e-01 | 0.083 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.294925e-01 | 0.081 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.336771e-01 | 0.079 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.336771e-01 | 0.079 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.336771e-01 | 0.079 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.336771e-01 | 0.079 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.336771e-01 | 0.079 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.356028e-01 | 0.078 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.376264e-01 | 0.077 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.378178e-01 | 0.077 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.417139e-01 | 0.075 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.417139e-01 | 0.075 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.417139e-01 | 0.075 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.417139e-01 | 0.075 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.417139e-01 | 0.075 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.417139e-01 | 0.075 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.417139e-01 | 0.075 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.417139e-01 | 0.075 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.417139e-01 | 0.075 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.417139e-01 | 0.075 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.420188e-01 | 0.075 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.420188e-01 | 0.075 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.420188e-01 | 0.075 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.420188e-01 | 0.075 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.420188e-01 | 0.075 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.420188e-01 | 0.075 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 8.420188e-01 | 0.075 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.420188e-01 | 0.075 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.420188e-01 | 0.075 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.420188e-01 | 0.075 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.448812e-01 | 0.073 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.510209e-01 | 0.070 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.531351e-01 | 0.069 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.531351e-01 | 0.069 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.531351e-01 | 0.069 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.536504e-01 | 0.069 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.566491e-01 | 0.067 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.566491e-01 | 0.067 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.566491e-01 | 0.067 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.566491e-01 | 0.067 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.566491e-01 | 0.067 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.566491e-01 | 0.067 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.566491e-01 | 0.067 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 8.566491e-01 | 0.067 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.566491e-01 | 0.067 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.566491e-01 | 0.067 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.593063e-01 | 0.066 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.598746e-01 | 0.066 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.600142e-01 | 0.065 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.628281e-01 | 0.064 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.628281e-01 | 0.064 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.637994e-01 | 0.064 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.637994e-01 | 0.064 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.637994e-01 | 0.064 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.637994e-01 | 0.064 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.642635e-01 | 0.063 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.654053e-01 | 0.063 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.699253e-01 | 0.061 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.699253e-01 | 0.061 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.699253e-01 | 0.061 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 8.699253e-01 | 0.061 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.699253e-01 | 0.061 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.699253e-01 | 0.061 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.699253e-01 | 0.061 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.699253e-01 | 0.061 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.699253e-01 | 0.061 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.699253e-01 | 0.061 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.699253e-01 | 0.061 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.699253e-01 | 0.061 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.699253e-01 | 0.061 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.736329e-01 | 0.059 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.736329e-01 | 0.059 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.737490e-01 | 0.059 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.737490e-01 | 0.059 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.765106e-01 | 0.057 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.789555e-01 | 0.056 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.819726e-01 | 0.055 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.819726e-01 | 0.055 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.819726e-01 | 0.055 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.819726e-01 | 0.055 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.819726e-01 | 0.055 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.819726e-01 | 0.055 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.819726e-01 | 0.055 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.819726e-01 | 0.055 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.820315e-01 | 0.055 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.830248e-01 | 0.054 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.873884e-01 | 0.052 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.874665e-01 | 0.052 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.916662e-01 | 0.050 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.916662e-01 | 0.050 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.916662e-01 | 0.050 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.916662e-01 | 0.050 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.929048e-01 | 0.049 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.929048e-01 | 0.049 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.929048e-01 | 0.049 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.929048e-01 | 0.049 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.929048e-01 | 0.049 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.946562e-01 | 0.048 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.946562e-01 | 0.048 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.946562e-01 | 0.048 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.951175e-01 | 0.048 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.953618e-01 | 0.048 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.997110e-01 | 0.046 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.997110e-01 | 0.046 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.008898e-01 | 0.045 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.028250e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.028250e-01 | 0.044 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.028250e-01 | 0.044 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.028250e-01 | 0.044 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.028250e-01 | 0.044 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.028250e-01 | 0.044 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.028250e-01 | 0.044 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.028250e-01 | 0.044 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.031581e-01 | 0.044 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.071957e-01 | 0.042 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.071957e-01 | 0.042 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.073493e-01 | 0.042 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.088473e-01 | 0.042 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.118268e-01 | 0.040 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.118268e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.118268e-01 | 0.040 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.118268e-01 | 0.040 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.118268e-01 | 0.040 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.140105e-01 | 0.039 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.141550e-01 | 0.039 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.141550e-01 | 0.039 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.141550e-01 | 0.039 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.141550e-01 | 0.039 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.159949e-01 | 0.038 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.196856e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.196856e-01 | 0.036 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.199952e-01 | 0.036 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.199952e-01 | 0.036 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.199952e-01 | 0.036 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.199952e-01 | 0.036 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.199952e-01 | 0.036 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.206219e-01 | 0.036 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.215248e-01 | 0.035 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.266278e-01 | 0.033 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.266278e-01 | 0.033 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.266278e-01 | 0.033 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.274073e-01 | 0.033 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.274073e-01 | 0.033 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.274073e-01 | 0.033 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.274073e-01 | 0.033 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.274073e-01 | 0.033 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.274073e-01 | 0.033 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.274073e-01 | 0.033 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.277234e-01 | 0.033 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.322028e-01 | 0.030 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.322028e-01 | 0.030 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.341332e-01 | 0.030 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.341332e-01 | 0.030 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.347531e-01 | 0.029 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.373750e-01 | 0.028 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.402362e-01 | 0.027 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.402362e-01 | 0.027 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.402362e-01 | 0.027 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.402362e-01 | 0.027 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.402362e-01 | 0.027 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.419307e-01 | 0.026 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.421713e-01 | 0.026 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.433002e-01 | 0.025 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.450360e-01 | 0.025 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.457740e-01 | 0.024 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.457740e-01 | 0.024 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.457740e-01 | 0.024 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.457740e-01 | 0.024 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.464278e-01 | 0.024 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.466168e-01 | 0.024 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.466168e-01 | 0.024 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.471728e-01 | 0.024 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.507353e-01 | 0.022 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.507353e-01 | 0.022 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.507353e-01 | 0.022 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.507353e-01 | 0.022 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.507991e-01 | 0.022 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.507991e-01 | 0.022 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.507991e-01 | 0.022 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.507991e-01 | 0.022 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.507991e-01 | 0.022 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.511547e-01 | 0.022 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.541900e-01 | 0.020 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.545493e-01 | 0.020 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.553587e-01 | 0.020 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.553587e-01 | 0.020 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.553587e-01 | 0.020 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.553587e-01 | 0.020 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.553587e-01 | 0.020 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.567549e-01 | 0.019 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.573623e-01 | 0.019 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.580798e-01 | 0.019 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.594960e-01 | 0.018 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.594960e-01 | 0.018 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.594960e-01 | 0.018 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.594960e-01 | 0.018 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.594960e-01 | 0.018 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.594960e-01 | 0.018 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.594960e-01 | 0.018 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.603277e-01 | 0.018 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.603277e-01 | 0.018 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.603277e-01 | 0.018 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.613466e-01 | 0.017 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.628360e-01 | 0.016 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.630985e-01 | 0.016 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.632501e-01 | 0.016 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.643682e-01 | 0.016 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.643682e-01 | 0.016 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.668788e-01 | 0.015 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.671620e-01 | 0.015 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.675588e-01 | 0.014 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.675588e-01 | 0.014 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.675588e-01 | 0.014 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.697442e-01 | 0.013 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.697472e-01 | 0.013 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.697472e-01 | 0.013 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.697472e-01 | 0.013 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.697472e-01 | 0.013 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.725517e-01 | 0.012 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.728366e-01 | 0.012 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.758485e-01 | 0.011 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.775717e-01 | 0.010 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.782470e-01 | 0.010 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.783766e-01 | 0.009 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.788535e-01 | 0.009 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.795001e-01 | 0.009 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.795001e-01 | 0.009 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.795001e-01 | 0.009 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.808025e-01 | 0.008 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.808538e-01 | 0.008 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.814009e-01 | 0.008 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.814009e-01 | 0.008 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.814009e-01 | 0.008 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.814009e-01 | 0.008 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.815793e-01 | 0.008 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.823917e-01 | 0.008 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.823917e-01 | 0.008 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.826651e-01 | 0.008 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.826651e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.831256e-01 | 0.007 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.836712e-01 | 0.007 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.846904e-01 | 0.007 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.846904e-01 | 0.007 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.847321e-01 | 0.007 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.856566e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.861102e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.861102e-01 | 0.006 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.861102e-01 | 0.006 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.864668e-01 | 0.006 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.873984e-01 | 0.006 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.873984e-01 | 0.006 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.881808e-01 | 0.005 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.885672e-01 | 0.005 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.886983e-01 | 0.005 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.888668e-01 | 0.005 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.896277e-01 | 0.005 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.896666e-01 | 0.005 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.897695e-01 | 0.004 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.897894e-01 | 0.004 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.898137e-01 | 0.004 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.901889e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.905176e-01 | 0.004 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.913655e-01 | 0.004 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.914628e-01 | 0.004 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.914628e-01 | 0.004 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.929734e-01 | 0.003 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.929734e-01 | 0.003 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.936253e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.936253e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.936253e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.938574e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.943652e-01 | 0.002 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.943652e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.947721e-01 | 0.002 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.948285e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.948285e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.948715e-01 | 0.002 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.952404e-01 | 0.002 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.960055e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.960828e-01 | 0.002 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.963359e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.964464e-01 | 0.002 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.966464e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.967763e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.967763e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.971743e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.972251e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.974769e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.974972e-01 | 0.001 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.976854e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.978232e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.980314e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.982034e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.982034e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.982484e-01 | 0.001 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.985216e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.985216e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.985216e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.986707e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.986791e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.987516e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.988873e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.989989e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.990919e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.993222e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.993222e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.993222e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.994942e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.995085e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.995412e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.995909e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.996576e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.996576e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.996584e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.996765e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.997637e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.997654e-01 | 0.000 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.997682e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.997682e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997898e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998085e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998102e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998102e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998710e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998820e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.998851e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999208e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999505e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999527e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999606e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999702e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999755e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999764e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999768e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999801e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999850e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999876e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999879e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999884e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999902e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999908e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999908e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999924e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999938e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999939e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999943e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999952e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999962e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999982e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999984e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999984e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999997e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999998e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |